Document:

[EXHIBIT 10.1]

                  AGREEMENT AND PLAN OF MERGER

     This AGREEMENT AND PLAN OF MERGER (the "Agreement") is made
                                             ---------
and entered into as of September 5, 2007, by and among
Dentalserv.com, a Nevada corporation ("Dentalserv.com") and
                                       --------------
Medpro Safety Products Inc., a Delaware corporation ("Medpro").
                                                      ------
                         R E C I T A L S
                         ---------------

     A.    The Boards of Directors of Dentalserv.com and Medpro
believe it is in the best interests of their respective companies
and the stockholders of their respective companies that
Dentalserv.com and Medpro combine into a single Dentalserv.com
through the statutory merger of Dentalserv.com and Medpro (the
"Merger") and, in furtherance thereof, have approved the Merger.
 ------
     B.    Pursuant to the Merger, among other things, the
outstanding shares of Medpro common stock, $.01 par value
("Medpro Common Stock"), shall be converted into shares of
  -------------------
Dentalserv.com Common Stock, $.001 par value ("Dentalserv.com
                                               --------------
Common Stock").
------------
     C.    Dentalserv.com and Medpro desire to make certain
representations and warranties and other agreements in connection
with the Merger.

     D.    The parties intend, by executing this Agreement, to
adopt a plan of reorganization within the meaning of Section 368
of the Internal Revenue Code of 1986, as amended (the "Code"),
                                                       ----
and to cause the Merger to qualify as a reorganization under the
provisions of Section 368 of the Code.

     NOW, THEREFORE, in consideration of the covenants and
representations set forth herein, and for other good and valuable
consideration the receipt and sufficiency of which is hereby
acknowledged, the parties hereto agree as follows:

                            ARTICLE I
                           THE MERGER
                           ----------

     1.1     The Merger. At the Effective Time (as defined in
             ----------
Section 1.2) and subject to and upon the terms and conditions of

this Agreement and the Certificate of Merger substantially in the
form attached hereto as Exhibit A and in accordance with the
applicable provisions of the Nevada Revised Statutes ("Nevada
                                                       ------
Law") and the Delaware General Corporation Law ("Delaware Law"),
---                                              ------------
Medpro shall be merged with and into Dentalserv.com, the separate
corporate existence of the Medpro shall cease and Dentalserv.com
shall continue as the surviving corporation and shall take the
name "Medpro Safety Products, Inc.". Dentalserv.com as the
surviving corporation after the Merger is hereinafter sometimes
referred to as the "Surviving Corporation."
                    ---------------------
     1.2     Closing; Effective Time. The closing of the
             -----------------------
transactions contemplated hereby (the "Closing") shall take place
                                       -------
as soon as practicable after the satisfaction or waiver of each
of the conditions set forth in Article VI hereof or at such other
                               ----------
time as the parties hereto agree (the "Closing Date"). The
                                       ------------
Closing shall take place at the offices of Lord, Bissell &
Brook LLP, 885 Third Avenue, 26th Floor, New York, NY 10022,
or at such other location as the parties hereto

<PAGE>

agree. In connection with the Closing, the parties hereto
shall cause the Merger to be consummated by filing the Certificate
of Merger with the Secretary of State of the State of Nevada, in
accordance with the relevant provisions of Nevada Law (the time
of such filing being the "Effective Time").  Promptly after the Closing,
                          --------------
a certified copy of the Certificate of Merger as filed with the Secretary
of State of the State of Nevada shall be filed with the Secretary of
State of the State of Delaware.

     1.3      Effect of the Merger. At the Effective Time, the
              --------------------
effect of the Merger shall be as provided in this Agreement, the
Certificate of Merger and the applicable provisions of Nevada Law
and Delaware Law. Without limiting the generality of the
foregoing, and subject thereto, at the Effective Time:

          (a)  all debts, liabilities and duties of Medpro shall
become the debts, liabilities and duties of the Surviving Corporation;

          (b)  the  Articles of Incorporation of  the Surviving
Corporation  shall be the Articles of Incorporation attached to
the Certificate of Merger as filed with the Secretary of State of
the State of Nevada, until thereafter amended as provided by law
and such Articles of Incorporation;

          (c)  the  Bylaws  of Medpro, as in effect immediately
prior to the Effective Time, shall be the Bylaws of the Surviving
Corporation, except as to the name of the Surviving Corporation,
which shall be  Medpro Safety Products, Inc., until thereafter
amended as provided by law, the Articles of Incorporation of the
Surviving Corporation and such Bylaws; and

          (d)  the persons  designated by Medpro on Schedule 6.2(e)
                                                    ---------------
shall become, in the manner set forth in Section 6.3(e), the
                                         --------------
directors and officers of the Surviving Corporation from and after
the Effective Time, in each case  until their respective successors
shall have been duly elected, designated or qualified, or until their
earlier death, resignation or removal in  accordance with the
Surviving  Corporation's Articles of Incorporation and Bylaws.

     1.4      Conversion of Medpro Common Stock. At the Effective
              ---------------------------------
Time, by virtue of the Merger and without any action on the part
of the holders of Medpro Common Stock or the holders of the
Dentalserv.com Common Stock, each of the 24,879,363 shares of
Medpro Common Stock, which will then constitute all of the issued
and outstanding shares of the capital stock of Medpro, shall be
converted into 11,878,628 fully paid and nonassessable shares of
Dentalserv.com Common Stock (the "Exchange Ratio").
                                  --------------
     1.5    Surrender of Certificates.
            -------------------------
          (a)  Exchange Agent.  The transfer agent of
               --------------
Dentalserv.com shall act as exchange agent (the "Exchange Agent")
                                                 --------------
in the Merger.

          (b)  Dentalserv.com to Provide Common Stock. Promptly
               --------------------------------------
after the Effective Time, Dentalserv.com shall make available to
the Exchange Agent for exchange in accordance with this Article I,
through such reasonable procedures as Dentalserv.com may adopt,
the shares of Dentalserv.com Common Stock into which the

                                  2
<PAGE>

shares of Medpro Common Stock outstanding immediately prior to
the Effective Time were converted pursuant to Section 1.4.
                                              -----------
          (c)  Exchange Procedures. Promptly after the Effective
               -------------------
Time, the Surviving Corporation shall cause the Exchange
Agent to mail to each holder of record of a certificate or
certificates (the "Certificates") which immediately prior to
                   ------------
the Effective Time represented outstanding shares of Medpro
Common Stock whose shares were converted into the right to
receive shares of Dentalserv.com Common Stock as set forth
in Section 1.4, pursuant to (i) a letter of transmittal and
   -----------
(ii) instructions for use in effecting the surrender of the
Certificates in exchange for certificates or agreements
representing shares of Medpro Common Stock. Upon surrender
of a Certificate to the Exchange Agent or to such other
agent or agents as may be appointed by the Surviving
Corporation, together with such letter of transmittal, duly
completed and validly executed in accordance with the
instructions thereto, the holder of such Certificate shall
be entitled to receive in exchange therefor a certificate
representing the number of whole shares of Dentalserv.com
Common Stock and the Certificate so surrendered shall
forthwith be canceled. Until so surrendered, each
outstanding Certificate that, prior to the Effective Time,
represented shares of Medpro Common Stock will be deemed
from and after the Effective Time, for all corporate
purposes, to evidence the ownership of the number of full
shares of Dentalserv.com Common Stock into which such shares
of Medpro Common Stock were otherwise converted at the
Effective Time.

          (d)  Transfers of Ownership. If any certificate for
               ----------------------
shares of Dentalserv.com Common Stock are to be issued in a
name other than that in which the Certificate surrendered in
exchange therefor is registered, it will be a condition of
the issuance thereof that the Certificate so surrendered be
accompanied by a duly completed and validly executed letter
of transmittal in proper form for transfer and that the
person requesting such exchange will have paid to Medpro or
any agent designated by it any transfer or other taxes
required by reason of the issuance of a certificate for
shares of Dentalserv.com Common Stock in any name other than
that of the registered holder of the Certificate
surrendered, or established to the satisfaction of the
Surviving Corporation or any agent designated by it that
such tax has been paid or is not payable.

     1.6     No Further Ownership Rights in Medpro Common Stock.
             --------------------------------------------------
All shares of Dentalserv.com Common Stock issued upon the
surrender of Certificates pursuant to Section 1.5(c) shall be
                                      --------------
deemed to have been issued in full satisfaction of all rights
pertaining to such securities, and there shall be no further
registration of transfers on the records of Medpro of shares of
Medpro Common Stock which were outstanding immediately prior to
the Effective Time. If, after the Effective Time, Certificates
are presented to the Surviving Corporation for any reason, they
shall be canceled and exchanged as provided in this Article I.

     1.7     Lost, Stolen or Destroyed Certificates. If any
             --------------------------------------
Certificates shall have been lost, stolen or destroyed, the
Exchange Agent shall issue in exchange for such lost, stolen or
destroyed Certificates, upon the making of an affidavit of that
fact by the holder thereof, such shares of Dentalserv.com Common
Stock as may be required pursuant to Section 1.4.
                                     -----------

                                  3
<PAGE>

     1.8     Tax Consequences. It is intended by the parties
             ----------------
hereto that the Merger shall constitute a reorganization within
the meaning of Section 368 of the Code.

     1.9     Withholding Rights.  The Surviving Corporation shall
             ------------------
be entitled to deduct and withhold from the number of shares of
Dentalserv.com Common Stock otherwise deliverable under this
Agreement, such amounts as the Surviving Corporation is required,
and Medpro acknowledges and agrees is required, to deduct and
withhold with respect to such delivery and payment under the Code
or any provision of state, local, provincial or foreign tax law.
To the extent that amounts are so withheld, such withheld amounts
shall be treated for all purposes of this Agreement as having
been delivered and paid to the former holder of shares of Medpro
Common Stock in respect of which such deduction and withholding
was made by the Surviving Corporation.

     1.10    Taking of Necessary Action; Further Action. If, at
             --------------------------
any time after the Effective Time, any further action is
necessary or desirable to carry out the purposes of this
Agreement and to vest the Surviving Corporation with full right,
title and possession to all assets, property, rights, privileges,
powers and franchises of Medpro, the officers and directors of
Medpro and Dentalserv.com are fully authorized in the name of
their respective corporations or otherwise to take, and will
take, all such lawful and necessary action, so long as such
action is not inconsistent with this Agreement

                           ARTICLE II

        REPRESENTATIONS AND WARRANTIES OF DENTALSERV.COM
        ------------------------------------------------

     In this Agreement, any reference to any event, change,
condition or effect being "material" with respect to any person
                           --------
means any material event, change, condition or effect related to
the condition (financial or otherwise), properties, assets
(including intangible assets), liabilities, business, operations
or results of operations of such person and its subsidiaries,
taken as a whole. In this Agreement, any reference to a "Material
                                                         --------
Adverse Effect" with respect to any person means any event,
--------------
change or effect that is materially adverse to the condition
(financial or otherwise), properties, assets, liabilities,
business, operations or results of operations of such person and
its subsidiaries, taken as a whole.

     Except as disclosed in that section of the document dated as
of the date of this Agreement and delivered by Dentalserv.com to
Medpro prior to the execution and delivery of this Agreement (the
"Dentalserv.com Disclosure Schedule") corresponding to the
Section of this Agreement to which any of the following
representations and warranties specifically relate or as
disclosed in another section of the Dentalserv.com Disclosure
Schedule unless it is reasonably apparent to Medpro from the
nature of the disclosure that it is applicable to another Section
of this Agreement, Dentalserv.com represents and warrants to
Medpro as follows:

     2.1    Organization, Standing and Power. Dentalserv.com is a
            --------------------------------
corporation duly organized, validly existing and in good
standing under the laws of the State of Nevada.  Dentalserv.com has
the power to own its properties and to carry on its business as now
being conducted and as presently proposed to be conducted and is
duly authorized and qualified to do

                                     4
<PAGE>

business and is in good standing in each jurisdiction in which the
failure to be so qualified and in good standing would have a Material
Adverse Effect on Dentalserv.com.  Dentalserv.com has delivered or
made available to Medpro a true and correct copy of the Articles of
Incorporation (the "Articles of Incorporation"), and the Bylaws,
                    -------------------------
or other charter documents, as applicable, of Dentalserv.com, as
amended to date.  Dentalserv.com is not in violation of any of
the provisions of its charter or bylaws.  Dentalserv.com does not
directly or indirectly own any equity or similar interest in, or
any interest convertible or exchangeable or exercisable for, any
equity or similar interest in, any corporation, partnership,
joint venture or other business association or entity.
Schedule 2.1 of the Dentalserv.com Disclosure Schedule lists, and
------------------------------------------------------
Dentalserv.com has delivered to Medpro copies of, the charters of
each committee of Dentalserv.com's Board of Directors and any
code of conduct or similar policy adopted by Dentalserv.com.

     2.2    Capital Structure. The authorized capital stock of
            -----------------
Dentalserv.com consists of 90,000,000 shares of common stock,
$0.001 par value, of which there were issued and outstanding as
of the close of business as of the date hereof, 1,396,000 shares
of Dentalserv.com Common Stock, along with 28,888,186 warrants to
purchase shares of Dentalserv.com Common Stock, and 10,000,000
shares of preferred stock, $0.001 par value (the "Dentalserv.com
                                                  --------------
Preferred Stock"), of which 6,668,230 were issued and outstanding
---------------
as of the close of business as of the date hereof. There are no
other outstanding shares of capital stock or voting securities
and no outstanding commitments to issue any shares of capital
stock or voting securities after the date hereof. All outstanding
shares of Dentalserv.com Common Stock are duly authorized,
validly issued, fully paid and non-assessable and are free of any
liens or encumbrances other than any liens or encumbrances
created by or imposed upon the holders thereof, and are not
subject to preemptive rights or rights of first refusal created
by statute, the Articles of Incorporation or Bylaws of
Dentalserv.com or any agreement to which Dentalserv.com is a
party or by which it is bound.

     2.3    Authority.  Dentalserv.com has all requisite corporate
            ---------
power and authority to enter into this Agreement and to
consummate the transactions contemplated hereby, subject only to
the adoption of this Agreement by Dentalserv.com's stockholders
holding a majority of the outstanding shares of Dentalserv.com
Common Stock.  The execution and delivery of this Agreement and
the consummation of the transactions contemplated hereby have
been duly authorized by all necessary corporate action on the
part of Dentalserv.com, subject only to the adoption of this
Agreement by Dentalserv.com's stockholders holding a majority of
the outstanding shares of Dentalserv.com Common Stock. This
Agreement has been duly executed and delivered by Dentalserv.com
and constitutes the valid and binding obligation of
Dentalserv.com enforceable against Dentalserv.com in accordance
with its terms, except as enforceability may be limited by
bankruptcy and other laws affecting the rights and remedies of
creditors generally and general principles of equity. The
execution and delivery of this Agreement by Dentalserv.com does
not, and the consummation of the transactions contemplated hereby
will not, conflict with, or result in any violation of, or
default under (with or without notice or lapse of time, or both),
or give rise to a right of termination, cancellation or
acceleration of any obligation or loss of any benefit under (i)
any provision of the Articles of Incorporation or Bylaws of
Dentalserv.com, as amended, or (ii) any material mortgage, indenture,
lease, contract or other agreement or instrument, permit, concession,
franchise, license, judgment, order, decree, statute, law, ordinance,
rule or regulation applicable to Dentalserv.com or any of its
properties or assets, except where such conflict, violation, default,
termination, cancellation or acceleration

                                  5
<PAGE>

with respect to the foregoing provisions of subsection (ii) above
could not have had and could not reasonably be expected to have a
Material Adverse Effect on Dentalserv.com. No consent, approval,
order or authorization of, or registration, declaration or filing
with, any court, administrative agency or commission or other
governmental authority or instrumentality ("Governmental Entity")
                                            -------------------
is required by or with respect to Dentalserv.com in connection
with the execution and delivery of this Agreement, or the
consummation of the transactions contemplated hereby and
thereby, except for (i) the filing of the Certificate of
Merger as provided in Section 1.2; (ii) the filing
                      -----------
with the SEC of Form D; (iii) the filing of a Form 8-K with the
SEC within four (4) business days after the Closing Date; (iv)
such consents, approvals, orders, authorizations, registrations,
declarations and filings as may be required under applicable
state securities laws and the securities laws of any foreign
country; (v) such filings, if any, as may be required under the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended
("HSR"); and (vi) such other consents, authorizations, filings,
  ---
approvals and registrations which, if not obtained or made, would
not have a Material Adverse Effect on Dentalserv.com and would
not prevent, or materially alter or delay any of the transactions
contemplated by this Agreement.

     2.4    Financial Statements. Dentalserv.com has provided to
            --------------------
Medpro a correct and complete copy of the audited consolidated
financial statements (including any related notes thereto) of
Dentalserv.com for the fiscal year ended December 31, 2006 (the
"Financial Statements"). The Financial Statements were prepared
 --------------------
in accordance with generally accepted accounting principles of
the United States ("GAAP") applied on a consistent basis
                    ----
throughout the periods involved (except as may be indicated in
the notes thereto), and each fairly presents in all material
respects the financial position of Dentalserv.com at the
respective dates thereof and the results of its operations and
cash flows for the periods indicated.

     2.5    Absence of Certain Changes. Since June 30, 2007 (the
            --------------------------
"Dentalserv.com Balance Sheet Date"), Dentalserv.com has
 ---------------------------------
conducted its business in the ordinary course consistent with
past practice and there has not occurred:  (i) any change, event
or condition that has resulted in, or is reasonably likely to
result in, or to the best of Dentalserv.com's knowledge any event
beyond Dentalserv.com's control that is reasonably likely to
result in, a Material Adverse Effect to Dentalserv.com; (ii) any
acquisition, sale or transfer of any material asset of
Dentalserv.com other than in the ordinary course of business and
consistent with past practice; (iii) any change in accounting
methods or practices by Dentalserv.com ; (iv) any declaration,
setting aside, or payment of a dividend or other distribution
with respect to the shares of Dentalserv.com, or any direct or
indirect redemption, purchase or other acquisition by
Dentalserv.com of any of its shares of capital stock; (v) any
material contract entered into by Dentalserv.com, other than in
the ordinary course of business, or any amendment or termination
of, or default under, any material contract to which
Dentalserv.com is a party; (vi) any amendment or change to
Dentalserv.com's Articles of Incorporation or Bylaws; or (vii)
any increase in or modification of the compensation or benefits
payable, or to become payable, by Dentalserv.com to any of its
directors or employees, other than pursuant to scheduled annual
performance reviews, provided that any resulting modifications
are in the ordinary course of business and consistent with
Dentalserv.com's past practices.  Dentalserv.com has not agreed
since June 30, 2007 to do any of the things described in the
preceding clauses (i) through (vii) and is not currently involved
in any negotiations to take any of the actions described in the
preceding clauses (i) through (vii) (other than negotiations with
Medpro and its representatives regarding the transactions
contemplated by this Agreement).

                                  6
<PAGE>

     2.6    Absence of Undisclosed Liabilities.  Dentalserv.com
            ----------------------------------
has no material obligations or liabilities of any nature (matured
or unmatured, fixed or contingent) other than (i) those set forth
or adequately provided for in the Balance Sheet included in
Financial Statements (the "Dentalserv.com Balance Sheet"), (ii)
                           ----------------------------
those incurred in the ordinary course of business and not
required to be set forth in Dentalserv.com Balance Sheet under
GAAP, (iii) those incurred in the ordinary course of business
since Dentalserv.com Balance Sheet date and not reasonably likely
to have a Material Adverse Effect on Dentalserv.com; and (iv)
those incurred in connection with the execution of this
Agreement.

     2.7    Litigation. There is no private or governmental
            ----------
action, suit, proceeding, claim, arbitration, audit or
investigation pending before any agency, court or tribunal,
foreign or domestic, or, to the knowledge of Dentalserv.com,
threatened against Dentalserv.com of its officers or directors
(in their capacities as such) that, individually or in the
aggregate, would reasonably be expected to have a Material
Adverse Effect on Dentalserv.com. There is no injunction,
judgment, decree, order or regulatory restriction imposed upon
Dentalserv.com or its assets or business, or, to the knowledge of
Dentalserv.com any of its directors or officers (in their
capacities as such), that would prevent, enjoin, alter or
materially delay any of the transactions contemplated by this
Agreement, or that could reasonably be expected to have a
Material Adverse Effect on Dentalserv.com. Schedule 2.7 of
                                           ---------------
Dentalserv.com Disclosure Schedule lists all actions, suits,
----------------------------------
proceedings, claims, arbitrations, audits and investigations
pending before any agency, court or tribunal that involve
Dentalserv.com.

     2.8    Restrictions on Business Activities. There is no
            -----------------------------------
agreement, judgment, injunction, order or decree binding upon
Dentalserv.com which has or reasonably could be expected to have
the effect of prohibiting or materially impairing any business
practice of  Dentalserv.com, any acquisition of property by
Dentalserv.com or the conduct of business by Dentalserv.com.

     2.9    Governmental Authorization. Dentalserv.com has
            --------------------------
obtained each federal, state, county, local or foreign
governmental consent, license, permit, grant, or other
authorization of a Governmental Entity (i) pursuant to which
Dentalserv.com currently operates or holds any interest in any of
its properties or (ii) that is required for the operation of
Dentalserv.com's business or the holding of any such interest
((i) and (ii) herein collectively called "Dentalserv.com
                                          --------------
Authorizations"), and all of such Dentalserv.com Authorizations
--------------
are in full force and effect, except where the failure to obtain
or have any of such Dentalserv.com Authorizations or where the
failure of such Dentalserv.com Authorizations to be in full force
and effect could not reasonably be expected to have a Material
Adverse Effect on Dentalserv.com.

     2.10   Title to Property. Dentalserv.com has good and valid
            -----------------
title to all of its properties, interests in properties and
assets, real and personal, reflected in Dentalserv.com Balance
Sheet.

     2.11   Intellectual Property. Dentalserv.com owns, or is
            ---------------------
licensed or otherwise possesses legally enforceable and unencumbered
rights to use, all patents, trademarks, trade names, service marks,
domain names, copyrights, and any applications therefor, maskworks,
schematics, trade secrets, computer software programs (in both
source code, except in circumstances where Dentalserv.com only
possesses a license to the object code form, and object

                                  7
<PAGE>

code form), and tangible or intangible proprietary information or
material ("Intellectual Property") that are used in the business
           ---------------------
of Dentalserv.com ("Dentalserv.com Intellectual Property").
                    ------------------------------------
     2.12    Taxes. Dentalserv.com properly completed and timely
             -----
filed all Tax Returns (as defined below) required to be filed by
them and have paid all Taxes (as defined below) required to be
paid, whether or not shown on any Tax Return. All unpaid Taxes of
Dentalserv.com and its subsidiaries for periods through December
30, 2006, are reflected in Dentalserv.com Balance Sheet.

     "Tax" or "Taxes" shall mean all taxes, charges, fees,
duties, levies, penalties or other assessments imposed by any
federal, state, local or foreign governmental authority,
including income, gross receipts, excise, property, sales, gain,
use, license, custom duty, unemployment, capital stock, transfer,
franchise, payroll, withholding, social security, minimum
estimated, profit, gift severance, value added, disability,
premium, recapture, credit, occupation, service, leasing,
employment, stamp and other taxes, and shall include interest,
penalties or addition attributable thereto or attributable to any
failure to comply with any requirement Tax Returns.

     "Tax Return" shall mean any return, declaration, report,
claim for refund, or information return or statement relating to
Taxes, including any such document prepared on a consolidated,
combined or unitary basis and also including any schedule or
attachment thereto and including any amendment thereof.

     2.13   Labor Matters. Dentalserv.com is not a party to any
            -------------
collective bargaining agreement or other labor union contract
applicable to persons employed by Dentalserv.com nor does
Dentalserv.com know of any activities or proceedings of any labor
union to organize any such employees.

     2.14   Compliance With Laws. To Dentalserv.com's knowledge,
            --------------------
Dentalserv.com has complied with, are not in violation of, and
have not received any notices of violation with respect to, any
federal, state, local or foreign statute, law or regulation with
respect to the conduct of its business, or the ownership or
operation of its business, except for such violations or failures
to comply as could not be reasonably expected to have a Material
Adverse Effect on Dentalserv.com.

     2.15   Minute Books. The minute books of Dentalserv.com made
            ------------
available to Medpro contain in all material respects a complete
and accurate summary of all meetings of directors and
stockholders or actions by written consent of Dentalserv.com
during the past three years and through the date of this
Agreement, and reflect all transactions referred to in such
minutes accurately in all material respects.

     2.16    Brokers' and Finders' Fees. Dentalserv.com has not
             --------------------------
incurred, nor will it incur, directly or indirectly, any
liability for brokerage or finders' fees or agents' commissions
or investment bankers' fees or any similar charges in connection
with this Agreement or any transaction contemplated hereby except
as disclosed on Schedule 2.16.

     2.17     Vote Required. The affirmative vote of
              -------------
Dentalserv.com's stockholders holding a majority of the outstanding
shares of Dentalserv.com Common Stock is the only vote of the

                                  8
<PAGE>

holders of any of Dentalserv.com's capital stock  necessary to
approve this Agreement and the transactions contemplated hereby.

     2.18    Board Approval. The Board of Directors of
             --------------
Dentalserv.com has (i) approved this Agreement and the Merger,
(ii) determined that this Agreement and the Merger are advisable
and in the best interests of the stockholders of Dentalserv.com
and are on terms that are fair to such stockholders and (iii)
intends to recommend that the stockholders of Dentalserv.com
approve this Agreement and consummation of the Merger.

     2.19    Over-the-Counter Bulletin Board Quotation.
             -----------------------------------------
Dentalserv.com Common Stock is quoted on the Over-the-Counter
Bulletin Board ("OTC BB"). There is no action or proceeding
                 ------
pending or, to Dentalserv.com's knowledge, threatened against
Dentalserv.com by Nasdaq or NASD, Inc. ("NASD") with respect to
                                         ----
any intention by such entities to prohibit or terminate the
quotation of Dentalserv.com Common Stock on the OTC BB.

     2.20    Representations Complete. None of the
             ------------------------
representations or warranties made by Dentalserv.com herein or in
any Schedule hereto, including the Dentalserv.com Disclosure
Schedule, or certificate furnished by Dentalserv.com pursuant to
this Agreement, when all such documents are read together in
their entirety, contains or will contain at the Effective Time
any untrue statement of a material fact, or omits or will omit at
the Effective Time to state any material fact necessary in order
to make the statements contained herein or therein, in the light
of the circumstances under which made, not misleading.

                           ARTICLE III
            REPRESENTATIONS AND WARRANTIES OF MEDPRO
            ----------------------------------------

     Except as disclosed in that section of the document dated as
of the date of this Agreement and delivered by Medpro to
Dentalserv.com prior to the execution and delivery of this
Agreement (the "Medpro Disclosure Schedule") corresponding to the
                --------------------------
Section of this Agreement to which any of the following representations
and warranties specifically relate or as disclosed in another section
of the Medpro Disclosure Schedule if it is reasonably applicable to
Medpro on the face of the disclosure that it is applicable to another
Section of this Agreement, Medpro represents and warrants to
Dentalserv.com as follows:

     3.1    Organization, Standing and Power. Medpro is a
            --------------------------------
corporation duly organized, validly existing and in good
standing, and no certificates of dissolutions have been filed
under the laws of its jurisdiction of organization.  Medpro and
its subsidiaries have the corporate power to own its properties
and to carry on its business as now being conducted and as
proposed to be conducted and is duly qualified to do business and
is in good standing in each jurisdiction in which the failure to
be so qualified and in good standing would have a Material
Adverse Effect on Medpro.  Medpro has delivered or made available
to Dentalserv.com a true and correct copy of the Certificate of
Incorporation (the "Certificate of Incorporation"), and the
                    ----------------------------
Bylaws, or other charter documents, as applicable, of Medpro, as
amended to date.  Medpro is not in violation of any of the
provisions of its charter or bylaws or equivalent organizational
documents.  Medpro is not in violation of any of the provisions
of its Certificate of Incorporation or Bylaws or equivalent
organizational documents.  Except as disclosed in Schedule 3.1 of
                                                  ---------------
the Medpro Disclosure Schedule, Medpro does not directly or
------------------------------
indirectly own any equity or similar interest in,

                                  9
<PAGE>

or any interest convertible or exchangeable or exercisable for,
any equity or similar interest in, any corporation, partnership,
joint venture or other business association or entity. Schedule 3.1
                                                       ------------
of the Medpro Disclosure Schedule lists, and Medpro has delivered to
---------------------------------
Dentalserv.com copies of, the charters of each committee of
Medpro's Board of Directors and any code of conduct or similar
policy adopted by Medpro.

     3.2    Capital Structure.  The authorized capital stock of
            -----------------
Medpro consists of 25,000,000 shares of common stock, $.01 par
value, of which 22,820,529 shares of Medpro Common Stock were
issued and outstanding as of the close of business on the date
hereof and 5,000,000 shares of preferred stock, $.01 par value,
none of which were issued and outstanding as of the close of
business on the date hereof.  Medpro has (a) convertible notes
outstanding which Medpro expects to be converted in accordance
with their terms, into 476,013.50 shares of Medpro Common Stock
before the Effective Time; and (b) agreements to convert debt and
other obligations of Medpro into 1,582,820.50 shares of Medpro
Common Stock before the Effective Time.  There are no other
outstanding shares of capital stock or voting securities and no
outstanding commitments to issue any shares of capital stock or
voting securities after the date hereof.  All outstanding shares
of Medpro Common Stock are duly authorized, validly issued, fully
paid and non-assessable and are free of any liens or encumbrances
other than any liens or encumbrances created by or imposed upon
the holders thereof, and are not subject to preemptive rights or
rights of first refusal created by statute, the Certificate of
Incorporation or Bylaws of Medpro or any agreement to which
Medpro is a party or by which it is bound.

     3.3   Authority. Medpro has all requisite corporate power
           ---------
and authority to enter into this Agreement and to consummate the
transactions contemplated hereby, subject only to the adoption of
this Agreement by Medpro's stockholders holding a majority of the
outstanding shares of Medpro Common Stock. The execution and
delivery of this Agreement and the consummation of the transactions
contemplated hereby has been duly authorized by all necessary corporate
action on the part of Medpro, subject only to the adoption of this
Agreement by Medpro's stockholders holding a majority of the outstanding
shares of Medpro Common Stock. This Agreement has been duly executed and
delivered by Medpro and constitutes the valid and binding obligation of
Medpro enforceable against Medpro in accordance with its terms, except
as enforceability may be limited by bankruptcy and other laws affecting
the rights and remedies of creditors generally and general principles
of equity. The execution and delivery of this Agreement does not,
and the consummation of the transactions contemplated hereby will
not, conflict with, or result in any violation of, or default under
(with or without notice or lapse of time, or both), or give rise
to a right of termination, cancellation or acceleration of any
obligation or loss of any benefit under (i) any provision of the
Certificate of Incorporation or Bylaws of Medpro or any of its
subsidiaries, as amended, or (ii) any material mortgage, indenture,
lease, contract or other agreement or instrument, permit, concession,
franchise, license, judgment, order, decree, statute, law,
ordinance, rule or regulation applicable to Medpro or any of its
subsidiaries or their properties or assets, except where such
conflict, violation, default, termination, cancellation or
acceleration with respect to the foregoing provisions of subsection
(ii) above could not have had and could not reasonably be expected
to have a Material Adverse Effect on Medpro.  No consent, approval,
order or authorization of, or registration, declaration or filing
with, any Governmental Entity, is required by or with respect to
Medpro or any of its subsidiaries in connection with the execution
and delivery of this Agreement by Medpro or the consummation by Medpro
of the transactions contemplated hereby, except for (i) the filing of the

                                  10
<PAGE>

Certificate of Merger as provided in Section 1.2; (ii) any filings
                                     -----------
as may be required under applicable state securities laws and the
securities laws of any foreign country; (v) any filings required
with the OTC BB with respect to the shares of Medpro Common Stock
issuable upon exchange of Dentalserv.com Common Stock in the
Merger; and (vi) such other consents, authorizations, filings,
approvals and registrations which, if not obtained or made, would
not have a Material Adverse Effect on Medpro and would not
prevent or materially alter or delay any of the transactions
contemplated by this Agreement.

     3.4     Financial Statements.  The financial statements of
             --------------------
Medpro provided to Dentalserv.com, including the notes thereto
(the "Medpro Financial Statements") were complete and correct in
      ---------------------------
all material respects as of their respective dates, complied as
to form in all material respects with applicable accounting
requirements, and have been prepared in accordance with GAAP
applied on a basis consistent throughout the periods indicated
and consistent with each other. The Medpro Financial Statements
fairly present the consolidated financial condition and operating
results of Medpro and its subsidiaries at the dates and during
the periods indicated therein (subject, in the case of unaudited
statements, to normal, recurring year-end adjustments).

     3.5     Absence of Certain Changes.  Since June 30, 2007
             --------------------------
(the "Medpro Balance Sheet Date"), Medpro has conducted its
      -------------------------
business in the ordinary course consistent with past practice and
there has not occurred: (i) any change, event or condition
(whether or not covered by insurance) that has resulted in, or is
reasonably likely to result in, or to the best of Medpro's
knowledge any event beyond Medpro's control that is reasonably
likely to result in, a Material Adverse Effect to Medpro; (ii)
any acquisition, sale or transfer of any material asset of Medpro
or any of its subsidiaries other than in the ordinary course of
business and consistent with past practice; (iii) any change in
accounting methods or practices (including any change in
depreciation or amortization policies or rates) by Medpro or any
revaluation by Medpro of any of its or any of its subsidiaries'
assets; (iv) any declaration, setting aside, or payment of a
dividend or other distribution with respect to the shares of
Medpro, or any direct or indirect redemption, purchase or other
acquisition by Medpro of any of its shares of capital stock; (v)
any material contract entered into by Medpro or any of its
subsidiaries, other than in the ordinary course of business, or
any amendment or termination of, or default under, any material
contract to which Medpro or any of its subsidiaries is a party or
by which it is bound; (vi) any amendment or change to Medpro's
Certificate of Incorporation or Bylaws except as required by the
transactions contemplated hereby; or (vii) any increase in or
modification of the compensation or benefits payable, or to
become payable, by Medpro to any of its directors or employees,
other than pursuant to scheduled annual performance reviews,
provided that any resulting modifications are in the ordinary
course of business and consistent with Medpro's past practices.
Medpro has not agreed since June 30, 2007 to do any of the things
described in the preceding clauses (i) through (vii) and is not
currently involved in any negotiations to take any of the actions
described in the preceding clauses (i) through (vii) (other than
negotiations with Dentalserv.com and its representatives
regarding the transactions contemplated by this Agreement).

     3.6    Absence of Undisclosed Liabilities.  Medpro has no
            ----------------------------------
material obligations or liabilities of any nature (matured or
unmatured, fixed or contingent) other than (i) the Balance Sheet
set forth on Schedule 3.6 of the Medpro Disclosure Schedule,
             ----------------------------------------------
dated as of December 31, 2006 (the "Medpro Balance Sheet"), (ii)
                                    --------------------
those incurred in the ordinary course of business and
not required to be set forth in the Medpro Balance Sheet
under GAAP, (iii) those incurred in the

                                  11
<PAGE>

ordinary course of business since the Medpro Balance Sheet date
and not reasonably likely to have a Material Adverse Effect on
Medpro, and (iv) those incurred in connection with this Agreement.

     3.7    Litigation. There is no private or governmental
            ----------
action, suit, proceeding, claim, arbitration, audit or
investigation pending before any agency, court or tribunal,
foreign or domestic, or, to the knowledge of Medpro or any of its
subsidiaries, threatened against Medpro or any of its
subsidiaries or any of their respective properties or any of
their respective officers or directors (in their capacities as
such) that, individually or in the aggregate, could reasonably be
expected to have a Material Adverse Effect on Medpro. There is no
injunction, judgment, decree, order or regulatory restriction
imposed upon Medpro or any of its subsidiaries or any of their
respective assets or business, or, to the knowledge of Medpro and
its subsidiaries, any of their respective directors or officers
(in their capacities as such), that would prevent, enjoin, alter
or materially delay any of the transactions contemplated by this
Agreement, or that could reasonably be expected to have a
Material Adverse Effect on Medpro. Schedule 3.7 of the Medpro
                                   --------------------------
Disclosure Schedule lists all actions, suits, proceedings,
-------------------
claims, arbitrations, audits and investigations pending before
any agency, court or tribunal that involve Medpro or any of its
subsidiaries.

     3.8    Restrictions on Business Activities. There is no
            -----------------------------------
agreement, judgment, injunction, order or decree binding upon
Medpro or any of its subsidiaries which has or reasonably could
be expected to have the effect of prohibiting or materially
impairing any business practice of Medpro or any of its
subsidiaries, any acquisition of property by Medpro or any of its
subsidiaries or the conduct of business by Medpro or any of its
subsidiaries.

     3.9   Taxes.
           -----
          (a)    Medpro and any consolidated, combined, unitary
     or aggregate group for Tax purposes of which Medpro is or
     has been a member, have properly completed and timely filed
     all Tax Returns required to be filed by them and have paid
     all Taxes required to be paid, whether or not shown on any
     Tax Return. All unpaid Taxes of Medpro for periods through
     December 31, 2006, are reflected in the Medpro Balance
     Sheet. Medpro has no liability for unpaid Taxes accruing
     after December 31, 2006, other than Taxes arising in the
     ordinary course of its business subsequent to December 31,
     2006.

          (b)    There is (i) no claim for Taxes that is a lien
     against the property of Medpro or is being asserted against
     Medpro other than liens for Taxes not yet due and payable;
     (ii) no audit of any Tax Return of Medpro that is being
     conducted by a Tax authority that is currently pending or
     threatened, and Medpro has not been notified of any proposed
     Tax claims or assessments against Medpro; (iii) no extension
     of the statute of limitations on the assessment of any Taxes
     that has been granted by Medpro and that is currently in
     effect; and (iv) no agreement, contract or arrangement to
     which Medpro is a party that may result in the payment of
     any amount that would not be deductible by reason of
     Sections 280G, 162 or 404 of the Code. Medpro has not been
     or will not be required to include any material adjustment
     in Taxable income for any Tax period (or portion thereof)
     pursuant to Section 481 or 263A of the Code or any comparable

                                  12
<PAGE>

     provision under state or foreign Tax laws as a result of
     transactions, events or accounting methods employed prior
     to the Merger.

          (c)    There are no Tax sharing or Tax allocation
     agreements to which Medpro is a party or to which it is
     bound. Medpro has not filed any disclosures under
     Section 6662 or comparable provisions of state, local or
     foreign law to prevent the imposition of penalties with
     respect to any Tax reporting position taken on any Tax
     Return. Medpro has never been a member of a consolidated,
     combined or unitary group of which Medpro was not the
     ultimate Medpro corporation. Medpro has in its possession
     receipts for any Taxes paid to foreign Tax authorities.

          (d)   Medpro has withheld (and paid over to the
     appropriate governmental authorities) with respect to either
     its employees or any third party all Taxes required to be
     withheld, including, but not limited to, FICA and FUTA.

          (e)    Medpro subsidiaries has never been a United
     States real property holding corporation within the meaning
     of Section 897 of the Code.

     3.10   Labor Matters. Medpro is not a party to any
            -------------
collective bargaining agreement or other labor union contract
applicable to persons employed by Medpro nor does Medpro know of
any activities or proceedings of any labor union to organize any
such employees.

     3.11   Intellectual Property.  Medpro owns, or is licensed
            ---------------------
or otherwise possesses legally enforceable and unencumbered
rights to use, all patents, trademarks, trade names, service
marks, domain names, copyrights, and any applications therefor,
maskworks, schematics, trade secrets, computer software programs
(in both source code, except in circumstances where Medpro only
possesses a license to the object code form, and object code
form), and tangible or intangible proprietary information or
material ("Intellectual Property") that are used in the business
           ---------------------
of Medpro ("Medpro Intellectual Property"). Medpro owns and
            ----------------------------
possesses source code for all software owned by Medpro and owns
or has valid licenses and possesses source code for all products
owned, distributed and presently supported by Medpro.

     3.12   Interested Party Transactions. Except as disclosed in
            -----------------------------
Schedule 3.12 of the Medpro Disclosure Schedule, Medpro is not
-----------------------------------------------
indebted to any director or officer of Medpro (except for amounts
due as normal salaries and bonuses and in reimbursement of
ordinary expenses), and no such person is indebted to Medpro.

     3.13   Compliance With Laws. Medpro has complied with, is
            --------------------
not in violation of, and has not received any notices of
violation with respect to, any federal, state, local or foreign
statute, law or regulation with respect to the conduct of its
business, or the ownership or operation of its business, except
for such violations or failures to comply as would not be
reasonably expected to have a Material Adverse Effect on Medpro.

     3.14   Broker's and Finders' Fees. Medpro has not incurred,
            --------------------------
nor will it incur, directly or indirectly, any liability for
brokerage or finders' fees or agents' commissions or investment
bankers' fees or any similar charges in connection with this
Agreement or any transaction contemplated hereby other than
payments to SC Capital Partners.

                                  13
<PAGE>

     3.15   Minute Books. The minute books of Medpro made
            ------------
available to Dentalserv.com contain in all material respects a
complete and accurate summary of all meetings of directors and
stockholders or actions by written consent of Medpro during the
past three years and through the date of this Agreement, and
reflect all transactions referred to in such minutes accurately
in all material respects.

     3.16   Vote Required. The affirmative vote of Medpro's
            -------------
stockholders holding a majority of the outstanding shares of
Medpro Common Stock is the only vote of the holders of any of
Medpro's capital stock necessary to approve this Agreement and
the transactions contemplated hereby.

     3.17   Board Approval. The Board of Directors of Medpro has
            --------------
(i) approved this Agreement and the Merger, (ii) determined that
this Agreement and the Merger are advisable and in the best
interests of the stockholders of Medpro and are on terms that are
fair to such stockholders and (iii) intends to recommend that the
stockholders of Medpro approve this Agreement and consummation of
the Merger.

     3.18   Representations Complete. None of the representations
            ------------------------
or warranties made by Medpro herein or in any Schedule hereto,
including the Medpro Disclosure Schedule, or certificate
furnished by Medpro pursuant to this Agreement, when all such
documents are read together in their entirety, contains or will
contain at the Effective Time any untrue statement of a material
fact, or omits or will omit at the Effective Time to state any
material fact necessary in order to make the statements contained
herein or therein, in the light of the circumstances under which
made, not misleading.

                           ARTICLE IV
               CONDUCT PRIOR TO THE EFFECTIVE TIME
               -----------------------------------

     4.1   Conduct of Business. During the period from the date
           -------------------
of this Agreement and continuing until the earlier of the
termination of this Agreement or the Effective Time, each of
Medpro and Dentalserv.com agrees (except to the extent expressly
contemplated by this Agreement or as consented to in writing by
the other party), to carry on its and its subsidiaries' business
in the ordinary course in substantially the same manner as
heretofore conducted, to pay and to cause its subsidiaries to pay
debts and Taxes when due, subject to good faith disputes over
such debts or taxes, to pay or perform other obligations when
due, and to use all reasonable efforts consistent with past
practice and policies to preserve intact its and its
subsidiaries' present business organizations, use its reasonable
best efforts consistent with past practice to keep available the
services of its and its subsidiaries' present officers and key
employees and use its reasonable best efforts consistent with
past practice to preserve its and its subsidiaries' relationships
with customers, suppliers, distributors, licensors, licensees,
and others having business dealings with it or its subsidiaries,
to the end that its and its subsidiaries' goodwill and ongoing
businesses shall be unimpaired at the Effective Time. Each of
Medpro and Dentalserv.com agrees to promptly notify the other of
any material event or occurrence not in the ordinary course of
its or its subsidiaries' business, and of any event that would
have a Material Adverse Effect on Medpro or Dentalserv.com.

                                  14
<PAGE>

     4.2   Restrictions on Conduct of Business. During the period
           -----------------------------------
from the date of this Agreement and continuing until the earlier
of the termination of this Agreement or the Effective Time,
except as expressly contemplated by this Agreement, neither
Medpro nor Dentalserv.com shall do, cause or permit any of the
following, or allow, cause or permit any of its subsidiaries to
do, cause or permit any of the following, without the prior
written consent of the other:

          (a)   Charter Documents. Cause or permit any amendments
                -----------------
     to its Certificate of Incorporation or Bylaws;

          (b)   Dividends; Changes in Capital Stock. Declare or
                -----------------------------------
     pay any dividends on or make any other distributions
     (whether in cash, stock or property) in respect of any of
     its capital stock, or split, combine or reclassify any of
     its capital stock or issue or authorize the issuance of any
     other securities in respect of, in lieu of or in
     substitution for shares of its capital stock, or repurchase
     or otherwise acquire, directly or indirectly, any shares of
     its capital stock except from former employees, directors
     and consultants in accordance with agreements providing for
     the repurchase of shares in connection with any termination
     of service to it or its subsidiaries;

          (c)   Stock Option Agreements, Etc. Take any action to
                ----------------------------
     accelerate, amend or change the period of exercisability or
     vesting of options or other rights granted under its stock
     option agreements or authorize cash payments in exchange for
     any options or other rights granted under any of such
     agreements, except changes that would allow accelerated
     vesting if holders of Dentalserv.com rights or options are
     terminated without cause within 12 months after the
     Effective Time;

          (d)   Material Contracts. Enter into any contract or
                ------------------
     commitment, or violate, amend or otherwise modify or waive
     any of the terms of any of its contracts, other than in the
     ordinary course of business consistent with past practice;

          (e)  Issuance of Securities. Except as set forth on
               ----------------------
     Schedule 4.2(e) and with respect to the private placement
     offering of up to $13,000,000.00 of Dentalserv.com Preferred
     Stock and warrants to purchase Dentalserv.com Common Stock,
     or the issuance of Medpro Common Stock in connection with
     the agency agreement between Medpro and SGPF, LLC, issue,
     deliver or sell or authorize or propose the issuance,
     delivery or sale of, or purchase or propose the purchase of,
     any shares of its capital stock or securities convertible
     into, or subscriptions, rights, warrants or options to
     acquire, or other agreements or commitments of any character
     obligating it to issue any such shares or other convertible
     securities, other than the issuance of shares of its common
     stock pursuant to the conversion of preferred stock, or
     exercise of stock options, warrants or other rights therefor
     outstanding as of the date of this Agreement;

          (f)  Dispositions. Sell, lease, license or otherwise
               ------------
     dispose of or encumber any of its properties or assets which
     are material, individually or in the aggregate, to its and
     its subsidiaries' business, taken as a whole, except in the
     ordinary course of business consistent with past practice;

                                  15
<PAGE>

          (g)   Indebtedness. Except in its ordinary course of
                ------------
     business, incur any indebtedness for borrowed money or
     guarantee any such indebtedness or issue or sell any debt
     securities or guarantee any debt securities of others in
     excess of $500,000.00 in the aggregate;

          (h)   Payment of Obligations. Pay, discharge or satisfy
                ---------------------
     in an amount in excess of $50,000.00 in any one case, any
     claim, liability or obligation (absolute, accrued, asserted
     or unasserted, contingent or otherwise) arising other than
     in the ordinary course of business, other than the payment,
     discharge or satisfaction of liabilities reflected or
     reserved against in the Medpro Financial Statements or
     Dentalserv.com Financial Statements, as applicable;

          (i)    Capital Expenditures. Make any capital
                 --------------------
     expenditures, capital additions or capital improvements
     except in the ordinary course of business and consistent
     with past practice that do not exceed $100,000.00
     individually or in the aggregate;

          (j)   Acquisitions. Except with respect to the issuance
                ------------
     of Medpro Common Stock in connection with the agency
     agreement between Medpro and SGPF, LLC, acquire by merging
     or consolidating with, or by purchasing a substantial
     portion of the assets of, or by any other manner, any
     business or any corporation, partnership, association or
     other business organization or division thereof, or
     otherwise acquire any assets which are material,
     individually or in the aggregate, to its and its
     subsidiaries' business, taken as a whole, or acquire any
     equity securities of any corporation, partnership,
     association or business organization;

          (k)    Taxes.  Other than in the ordinary course of
                 -----
     business, make or change any material election in respect of
     Taxes, adopt or change any accounting method in respect of
     Taxes, file any material Tax Return or any amendment to a
     material Tax Return, enter into any closing agreement,
     settle any claim or assessment in respect of Taxes, or
     consent to any extension or waiver of the limitation period
     applicable to any claim or assessment in respect of Taxes;

          (l)    Revaluation. Revalue any of its assets,
                 -----------
     including without limitation writing down the value of
     inventory or writing off notes or accounts receivable other
     than in the ordinary course of business;

          (m)   Accounting Policies and Procedures.  Make any
                ----------------------------------
     change to its accounting methods, principles, policies,
     procedures or practices, except as may be required by GAAP,
     Regulation S-X promulgated by the SEC or applicable
     statutory accounting principles;

          (n)   Other. Take or agree in writing or otherwise to
                -----
     take, any of the actions described in Sections 4.2(a)
                                           ---------------
     through (m) above, or any action which would make any of its
     -----------
     representations or warranties contained in this Agreement
     untrue or incorrect or prevent it from performing or cause
     it not to perform its covenants hereunder.

                                  16
<PAGE>

                            ARTICLE V
                      ADDITIONAL AGREEMENTS
                      ---------------------

     5.1   Effectiveness of the Merger. Dentalserv.com shall
           ---------------------------
promptly after the date hereof take all action necessary in
accordance with Nevada Law and its Certificate of Incorporation
and Bylaws to approve the Merger within 45 days of the date of
this Agreement.

     5.2   Access to Information.
           ---------------------

          (a)   Except as prohibited by applicable law, each of
     Medpro and Dentalserv.com shall afford the other and its
     accountants, counsel and other representatives, reasonable
     access during normal business hours during the period prior
     to the Effective Time to (i) all of such party's and its
     subsidiaries' properties, books, contracts, commitments and
     records, and (ii) all other information concerning the
     business, properties and personnel of such party and its
     subsidiaries as the other party may reasonably request. Each
     of Medpro and Dentalserv.com agree to provide to the other
     and its accountants, counsel and other representatives
     copies of internal financial statements promptly upon
     request.

          (b)   Subject to compliance with applicable law, from
     the date hereof until the Effective Time, each of Medpro and
     Dentalserv.com shall confer on a regular and frequent basis
     with one or more representatives of the other party to
     report operational matters of materiality and the general
     status of ongoing operations.

          (c)   No information or knowledge obtained in any
     investigation pursuant to this Section 5.2 shall affect or
                                    -----------
     be deemed to modify any representation or warranty contained
     herein or the conditions to the obligations of the parties
     to consummate the Merger.

     5.3    Confidential Information; Non-Solicitation or Negotiation.
            ---------------------------------------------------------

          (a)  Confidential Information. Except in connection
               ------------------------
     with any dispute between the parties and subject to any
     obligation to comply with (i) any applicable law, (ii) any
     rule or regulation of any governmental authority or
     securities exchange, or (iii) any subpoena or other legal
     process to make information available to the persons
     entitled thereto, whether or not the transactions
     contemplated herein shall be concluded, all information
     obtained by any party about any other, and all of the
     terms and conditions of this Agreement, shall be kept in
     confidence by each party, and each party shall cause its
     stockholders, directors, officers, managers, employees,
     agents and attorneys to hold such information confidential.
     Such confidentiality shall be maintained to the same degree
     as such party maintains its own confidential information and
     shall be maintained until such time, if any, as any such
     data or information either is, or becomes, published or a
     matter of public knowledge; provided, however, that the
     foregoing shall not apply to any information received by
     a party from a source not known by such party to be bound
     by a confidentiality agreement with, or other contractual,
     legal or fiduciary obligation of confidentiality to, the
     other party, nor to any information obtained by a party
     which is generally known to others engaged in the trade or
     business of such party.  In the event a

                                  17
<PAGE>

     party to this Agreement becomes legally compelled to
     disclose any such information, it shall promptly provide the
     others with written notice of such requirement so that the other
     parties to this Agreement may seek a protective order or other
     remedy.  If this Agreement shall be terminated for any reason, the
     parties shall return or cause to be returned to the others all
     written data, information, files, records and copies of
     documents, worksheets and other materials obtained by such
     parties in connection with this Agreement.

          (b)    No Solicitation or Negotiation. Unless and until
                 ------------------------------
     this Agreement is terminated, Medpro shall not cause, suffer
     or permit its directors, officers, stockholders, employees,
     representatives, agents, investment bankers, advisors,
     accountants or attorneys to initiate or solicit, directly or
     indirectly, any inquiries or the making of any offer or
     proposal that constitutes or could be reasonably expected to
     lead to an a proposal or offer (other than by
     Dentalserv.com) for a stock purchase, asset acquisition,
     merger, consolidation or other business combination
     involving Medpro or any proposal to acquire in any manner a
     direct or indirect substantial equity interest in, or all or
     any substantial part of the assets of Medpro (an
     "Alternative Proposal") from any person and/or entity, or
     engage in negotiations or discussions relating thereto or
     accept any Alternative Proposal, or make or authorize any
     statement, recommendation or solicitation in support of any
     Alternative Proposal.  Medpro shall notify Dentalserv.com
     orally and in writing of the receipt of any such inquiries,
     offers or proposals (including the terms and conditions of
     any such offer or proposal, the identity of the person
     and/or entity making it and a copy of any written
     Alternative Proposal), as promptly as practicable and in any
     event within 48 hours after the receipt thereof, and shall
     keep Dentalserv.com informed of the status and details of
     any such inquiry, offer or proposal.  Medpro shall
     immediately terminate any existing solicitation, activity,
     discussion or negotiation with any person and/or entity
     hereafter conducted by any officer, employee, director,
     stockholder or other representative thereof with respect to
     the foregoing.

     5.4    Public Disclosure. Unless otherwise permitted by this
            -----------------
Agreement, Medpro and Dentalserv.com shall consult with each
other before issuing any press release or otherwise making any
public statement or making any other public (or non-confidential)
disclosure (whether or not in response to an inquiry) regarding
the terms of this Agreement and the transactions contemplated
hereby, and neither shall issue any such press release or make
any such statement or disclosure without the prior approval of
the other (which approval shall not be unreasonably withheld),
except as may be required by the SEC or by obligations pursuant
to any listing agreement with any national securities exchange or
with the NASD, in which case the party proposing to issue such
press release or make such public statement or disclosure shall
use its commercially reasonable efforts to consult with the other
party before issuing such press release or making such public
statement or disclosure.

     5.5    Consents.
            --------

     Each of Medpro and Dentalserv.com shall promptly apply for
or otherwise seek, and use its reasonable best efforts to obtain,
all consents and approvals required to be obtained by it for the
consummation of the Merger, including those required under HSR.
The parties hereto will consult and cooperate with one another,
and consider in good faith the views of one another, in connection
with any analyses, appearances, presentations, memoranda, briefs, arguments,

                                  18
<PAGE>

opinions and proposals made or submitted by or on behalf of any party
hereto in connection with proceedings under or relating to HSR or any
other federal or state antitrust or fair trade law.

     5.6    Legal Requirements. Each of Medpro and Dentalserv.com
            ------------------
will, and will cause their respective subsidiaries to, take all
reasonable actions necessary to comply promptly with all legal
requirements which may be imposed on them with respect to the
consummation of the transactions contemplated by this Agreement
and will promptly cooperate with and furnish information to any
party hereto necessary in connection with any such requirements
imposed upon such other party in connection with the consummation
of the transactions contemplated by this Agreement and will take
all reasonable actions necessary to obtain (and will cooperate
with the other parties hereto in obtaining) any consent,
approval, order or authorization of, or any registration,
declaration or filing with, any Governmental Entity or other
person, required to be obtained or made in connection with the
taking of any action contemplated by this Agreement.

     5.7    Blue Sky Laws. Medpro shall use its reasonable best
            -------------
efforts to comply with the securities and blue sky laws of all
jurisdictions which are applicable to the issuance of the Medpro
Common Stock in connection with the Merger.  Dentalserv.com shall
use its reasonable best efforts to assist Medpro as may be
necessary to comply with the securities and blue sky laws of all
jurisdictions which are applicable in connection with the
issuance of Medpro Common Stock in connection with the Merger.

     5.8   Form 8-K. At least five (5) days prior to Closing,
           --------
Dentalserv.com shall prepare a draft Form 8-K announcing the
Closing, together with, or incorporating by reference, the
financial statements prepared by Dentalserv.com and its
accountant, and such other information that may be required to be
disclosed with respect to the Merger in any report or form to be
filed with the SEC ("Merger Form 8-K"), which shall be in a form
                     ---------------
reasonably acceptable to Medpro. Prior to Closing, Medpro and
Dentalserv.com will prepare the press release announcing the
consummation of the Merger hereunder ("Press Release").
                                       -------------
Simultaneously with the Closing, Medpro shall file and distribute
the Press Release.  Within four (4) business days after the
Closing, the Surviving Corporation shall file the Merger Form 8-K
with the SEC.

     5.9   Indemnification.
           ---------------

          (a)    After the Effective Time, the Surviving
     Corporation will fulfill and honor in all respects (i) the
     obligations of Dentalserv.com pursuant to the
     indemnification provisions of Dentalserv.com's Articles of
     Incorporation and Bylaws or any indemnification agreement
     with Dentalserv.com officers and directors to which
     Dentalserv.com is a party, and (ii) the obligations of
     Medpro pursuant to the indemnification provisions of
     Medpro's Certificate of Incorporation and Bylaws or any
     indemnification agreement with Medpro officers and directors
     to which Medpro is a party, in each case in effect on the
     date hereof; provided that such indemnification shall be
     subject to any limitation imposed from time to time under
     applicable law.  All such indemnification agreements are
     forth on Schedule 5.9 of the Dentalserv.com Disclosure
              ---------------------------------------------
     Schedule or Schedule 5.9 of the Medpro Disclosure Schedule,
     --------    ----------------------------------------------
     as applicable.  Without limitation of the foregoing, in the
     event any person so indemnified (an "Indemnified Party") is
                                          -----------------
     or becomes involved in any capacity in any action,
     proceeding or investigation in connection with any matter
     relating to this Agreement or the transactions contemplated

                                  19
<PAGE>

     hereby occurring on or prior to the Effective Time,
     Dentalserv.com or Medpro (as the case may be) shall pay as
     incurred such Indemnified Party's reasonable legal and other
     expenses (including the cost of any investigation and
     preparation) incurred in connection therewith to the fullest
     extent permitted by the Law . Any Indemnified Party wishing
     to claim indemnification under this Section 5.9, upon
                                         -----------
     learning of any such claim, action, suit, proceeding or
     investigation, shall promptly notify Dentalserv.com, Medpro,
     or the Surviving Corporation (as the case may be, the
     "Indemnifying Party") of such claim.

          (b)    To the extent there is any claim, action, suit,
     proceeding or investigation (whether arising before or after
     the Effective Time) against an Indemnified Party that arises
     out of or pertains to any action or omission in his or her
     capacity as director, officer, employee, fiduciary or agent
     of either Dentalserv.com or Medpro occurring before the
     Effective Time, or arises out of or pertains to the
     transactions contemplated by this Agreement for a period
     lasting until the expiration of five years after the
     Effective Time (whether arising before or after the
     Effective Time), in each case for which such Indemnified
     Party is indemnified under this Section 5.9, such
                                     -----------
     Indemnified Party shall be entitled to be represented by
     counsel, which counsel shall be selected by the Indemnifying
     Party (provided that if use of such counsel would be
     expected under applicable standards of professional conduct
     to give rise to a conflict between the position of the
     Indemnified Person and of the Indemnifying Party, the
     Indemnified Party shall be entitled instead to be
     represented by counsel selected by the Indemnified Party and
     reasonably acceptable to the Indemnifying Party) and
     following the Effective Time, the the Indemnifying Party
     shall pay the reasonable fees and expenses of such counsel,
     promptly after statements therefor are received and the
     Indemnifying Party will cooperate in the defense of any such
     matter; provided, however, that the Indemnifying Party shall
     not be liable for any settlement effected without its
     written consent (which consent shall not be unreasonably
     withheld); and provided, further, that, in the event that
     any claim or claims for indemnification are asserted or made
     prior to the expiration of such five year period, all rights
     to indemnification in respect to any such claim or claims
     shall continue until the disposition of any and all such
     claims. The Indemnified Parties as a group may retain only
     one law firm (in addition to local counsel) to represent
     them with respect to any single action unless there is,
     under applicable standards of professional conduct, a
     conflict on any significant issue between the position of
     any two or more Indemnified Parties.

          (c)   The provisions of this Section 5.9 are intended
                                       -----------
     to be for the benefit of, and shall be enforceable by, each
     Indemnified Party, his or her heirs and representatives.

     5.10   Tax Treatment. For U.S. federal income tax purposes,
            -------------
it is intended that the Merger qualify as a reorganization within
the meaning of the Code, and the parties hereto intend that this
Agreement shall constitute a "plan of reorganization" within the
meaning of Section 368 of the Code and Treasury Regulations
Sections 1.368-2(g) and 1.368-3(a). the Surviving Corporation
will report the Merger on its income tax returns in a manner
consistent with treatment of the Merger as a Code Section 368(a)
reorganization. Neither Medpro, Dentalserv.com nor any of there
respective affiliates has taken any action, nor will they take
any action, that could reasonably be expected to prevent or
impede the Merger from qualifying as a reorganization under
Section 368 of the Code.

                                  20
<PAGE>

     5.11   Best Efforts and Further Assurances. Each of the
            -----------------------------------
parties to this Agreement shall use its best efforts to
effectuate the transactions contemplated hereby and to fulfill
and cause to be fulfilled the conditions to closing under this
Agreement. Each party hereto, at the reasonable request of
another party hereto, shall execute and deliver such other
instruments and do and perform such other acts and things as may
be necessary or desirable for effecting completely the
consummation of this Agreement and the transactions contemplated
hereby.

                           ARTICLE VI
                    CONDITIONS TO THE MERGER
                    ------------------------

     6.1   Conditions to Obligations of Each Party to Effect the
           -----------------------------------------------------
Merger. The respective obligations of each party to this
------
Agreement to consummate and effect this Agreement and the
transactions contemplated hereby shall be subject to the
satisfaction at or prior to the Effective Time of each of the
following conditions, any of which may be waived, in writing, by
agreement of all the parties hereto:

          (a)    Stockholder Approval. This Agreement and the
                 --------------------
     Merger shall have been approved and adopted by the requisite
     vote of the stockholders of Dentalserv.com under Nevada Law
     and by the requisite vote of the stockholders of Medpro
     under Delaware Law.

          (b)    No Injunctions or Restraints; Illegality. No
                 ----------------------------------------
     temporary restraining order, preliminary or permanent
     injunction or other order issued by any court of competent
     jurisdiction or other legal or regulatory restraint or
     prohibition preventing the consummation of the Merger shall
     be in effect, nor shall any proceeding brought by an
     administrative agency or commission or other governmental
     authority or instrumentality, domestic or foreign, seeking
     any of the foregoing be pending; nor shall there be any
     action taken, or any statute, rule, regulation or order
     enacted, entered, enforced or deemed applicable to the
     Merger, which makes the consummation of the Merger illegal.
     In the event an injunction or other order shall have been
     issued, each party agrees to use its reasonable best efforts
     to have such injunction or other order lifted.

          (c)    Governmental Approvals. Medpro, Dentalserv.com
                 ----------------------
     and their respective subsidiaries shall have timely obtained
     from each Governmental Entity all approvals, waivers and
     consents, if any, necessary for consummation of or in
     connection with the Merger and the several transactions
     contemplated hereby, including such approvals, waivers and
     consents as may be required under the Securities Act, under
     state Blue Sky laws, and under HSR.

     6.2     Additional Conditions to Obligations of
             ---------------------------------------
Dentalserv.com. The obligations of Dentalserv.com to consummate
--------------
and effect this Agreement and the transactions contemplated
hereby shall be subject to the satisfaction at or prior to the
Effective Time of each of the following conditions, any of which
may be waived, in writing, by Dentalserv.com:

          (a)   Representations, Warranties and Covenants. (i)
                -----------------------------------------
     The representations and warranties of Medpro in this Agreement
     shall be true and correct in all material respects (except for
     such representations and warranties that are qualified by their terms

                                  21
<PAGE>

     by a reference to materiality which representations and
     warranties as so qualified shall be true and correct in
     all respects) both when made and on and as of the Effective
     Time as though such representations and warranties were
     made on and as of such time (provided that those
     representations and warranties which address matters only
     as of a particular date shall be true and correct as of
     such date) and (ii) Medpro shall have performed and complied
     in all material respects with all covenants, obligations and
     conditions of this Agreement required to be performed and
     complied with by them as of the Effective Time.

          (b)   Certificate of Medpro. Dentalserv.com shall have
                ---------------------
     been provided with a certificate executed on behalf of
     Medpro by its President and Chief Financial Officer
     certifying that the conditions set forth in Section 6.2(a)
     shall have been fulfilled.

          (c)   Third Party Consents. Dentalserv.com shall have
                --------------------
     been furnished with evidence satisfactory to it of the
     consent or approval of those persons whose consent or
     approval shall be required in connection with the Merger
     under the contracts of Medpro set forth on Schedule 6.2(c)
     of the Medpro Disclosure Schedule.

          (d)   Injunctions or Restraints on Conduct of Business.
                ------------------------------------------------
     No temporary restraining order, preliminary or permanent
     injunction or other order issued by any court of competent
     jurisdiction or other legal or regulatory restraint
     provision limiting or restricting Medpro's conduct or
     operation of the business of Medpro and its subsidiaries,
     following the Merger shall be in effect, nor shall any
     proceeding brought by an administrative agency or commission
     or other Governmental Entity, domestic or foreign, seeking
     the foregoing be pending.

          (e)   No Material Adverse Changes. There shall not have
                ---------------------------
     occurred any Material Adverse Effect on Medpro, or any
     change that has a Material Adverse Effect on Medpro.

          6.3   Additional Conditions to the Obligations of
                -------------------------------------------
     Medpro. The obligations of Medpro to consummate and effect
     ------
     this Agreement and the transactions contemplated hereby
     shall be subject to the satisfaction at or prior to the
     Effective Time of each of the following conditions, any of
     which may be waived, in writing, by Medpro:

          (a)   Representations, Warranties and Covenants. (i)
                -----------------------------------------
     The representations and warranties of Dentalserv.com in this
     Agreement shall be true and correct in all material respects
     (except for such representations and warranties that are
     qualified by their terms by a reference to materiality,
     which representations and warranties as so qualified shall
     be true and correct in all respects) both when made and on
     and as of the Effective Time as though such representations
     and warranties were made on and as of such time (provided
     that those representations and warranties which address
     matters only as of a particular date shall be true and
     correct as of such date) and (ii) Dentalserv.com shall have
     performed and complied in all material respects with all
     covenants, obligations and conditions of this Agreement
     required to be performed and complied with by it as of the
     Effective Time.

                                  22
<PAGE>

          (b)   Certificate of Dentalserv.com.  Medpro shall have
                -----------------------------
     been provided with a certificate executed on behalf of
     Dentalserv.com by its President and Chief Financial Officer
     certifying that the conditions set forth in Section 6.3(a)
     shall have been fulfilled.

          (c)   Injunctions or Restraints on Conduct of Business.
                ------------------------------------------------
     No temporary restraining order, preliminary or permanent
     injunction or other order issued by any court of competent
     jurisdiction or other legal or regulatory restraint
     provision limiting or restricting Dentalserv.com's conduct
     or operation of the business of Dentalserv.com following the
     Merger shall be in effect, nor shall any proceeding brought
     by an administrative agency or commission or other
     Governmental Entity, domestic or foreign, seeking the
     foregoing be pending.

          (d)   No Material Adverse Changes. There shall not have
                ---------------------------
     occurred any Material Adverse Effect on Dentalserv.com, or
     any change that has a Material Adverse Effect on
     Dentalserv.com.

          (e)  Officers and Directors of Dentalserv.com.
               ----------------------------------------
     Dentalserv.com shall have obtained and delivered to Medpro
     copies of the resignations of those persons listed on
     Schedule 6.3(e) from their positions as officers and
     ---------------
     directors of Dentalserv.com, and shall have taken all
     necessary action for the appointment of the persons listed
     on Schedule 6.2(e) to the positions set forth opposite their
        ---------------
     names, all effective at and as of the Closing.  Immediately
     prior to the effectiveness of the resignations of the
     directors of Dentalserv.com, the directors of Dentalserv.com
     shall have appointed persons designated by Medpro to fill
     vacancies on Dentalserv.com's board of directors, including,
     if applicable, vacancies created by the resignations
     described herein.

          (f)   Stock Quotation. Dentalserv.com Common Stock at
                ---------------
     Closing shall be quoted on the OTC BB, and there will be no
     action or proceeding pending or threatened against
     Dentalserv.com by the NASD to prohibit or terminate the
     quotation of Dentalserv.com Common Stock on the OTC BB.

          (g)  SEC Compliance. Immediately prior to the Closing,
               --------------
     Dentalserv.com shall be in compliance with the reporting
     requirements under the Exchange Act, and shall have timely
     filed all Exchange Act reports for the twelve month period
     preceding the Closing.

                           ARTICLE VII
                TERMINATION, AMENDMENT AND WAIVER
                ---------------------------------

     7.1    Termination. At any time prior to the Effective Time,
            -----------
whether before or after approval of the matters presented in
connection with the Merger by the stockholders of Dentalserv.com,
this Agreement may be terminated:

          (a)  by mutual consent of Medpro and Dentalserv.com;

          (b)  by either Medpro or Dentalserv.com, if, without
     fault of the terminating party, the Closing shall not have
     occurred on or before October 31, 2007, or such later date
     as may be agreed upon in writing by the parties hereto (the
     "Final Date");
      ----------

                                  23
<PAGE>

          (c)  by Medpro, if Dentalserv.com breaches any of its
     representations, warranties or obligations hereunder to an
     extent that would cause the condition set forth in
     Section 6.3(a) not to be satisfied and such breach shall not
     --------------
     have been cured within ten (10) business days of receipt by
     Dentalserv.com of written notice of such breach (and Medpro
     has not willfully breached any of its covenants hereunder,
     which breach is not cured);

          (d)  by Dentalserv.com, if Medpro breaches any of its
     representations, warranties or obligations hereunder to an
     extent that would cause the condition set forth in
     Section 6.2(a) not to be satisfied and such breach shall not
     --------------
     have been cured within ten (10) business days of receipt by
     Medpro of written notice of such breach (and Dentalserv.com
     has not willfully breached any of its covenants hereunder,
     which breach is not cured); or

          (e)   by either Medpro or Dentalserv.com if (i) any
     permanent injunction or other order of a court or other
     competent authority preventing the consummation of the
     Merger shall have become final and nonappealable or (ii) any
     required approval of the stockholders of Medpro or
     Dentalserv.com shall not have been obtained by reason of the
     failure to obtain the required vote upon a vote held at a
     duly held meeting of stockholders or at any adjournment
     thereof (provided that the right to terminate this Agreement
     under this subsection (ii) shall not be available to Medpro
     or Dentalserv.com where the failure to obtain such
     stockholder approval shall have been caused by the action or
     failure to act of Medpro or Dentalserv.com and such action
     or failure constitutes a breach by Medpro or Dentalserv.com
     of this Agreement).

     7.2   Effect of Termination. In the event of termination of
           ---------------------
this Agreement as provided in Section 7.1, this Agreement shall
                              -----------
forthwith become void and there shall be no liability or
obligation on the part of Medpro or Dentalserv.com or their
respective officers, directors, stockholders or affiliates,
except to the extent that such termination results from the
breach by a party hereto of any of its representations,
warranties or covenants set forth in this Agreement; provided
that, the provisions of Section 5.3 (Confidentiality),
                        -----------
Section 7.3 (Expenses and Termination Fees), this Section 7.2 and
-----------                                       -----------
Section 8.1 (Non-Survival at Effective Time) shall remain in full
-----------
force and effect and survive any termination of this Agreement.
Nothing herein shall relieve any party from liability in
connection with a breach by such party of the representations,
warranties or covenants of such party to this Agreement.

     7.3    Expenses and Termination Fees.
            -----------------------------

          (a)  Subject to subsections (b) and (c) of this
     Section 7.3, whether or not the Merger is consummated, all
     -----------
     costs and expenses incurred in connection with this
     Agreement and the transactions contemplated hereby
     (including, without limitation, the fees and expenses of its
     advisers, accountants and legal counsel) shall be paid by
     the party incurring such expense.

          (b)  If Medpro terminates this Agreement pursuant to
     Section 7.1(c) then Dentalserv.com shall promptly reimburse
     --------------
     Medpro for all of the out-of-pocket costs and expenses incurred
     by Medpro in connection with this Agreement and the transactions

                                  24
<PAGE>

     contemplated hereby (including, without limitation, the fees and
     expenses of its advisors, accountants and legal counsel).

          (c)  If Dentalserv.com terminates this Agreement
     pursuant to Section 7.1(d) Medpro shall promptly reimburse
                 --------------
     Dentalserv.com for all of the out-of-pocket costs and
     expenses incurred by Dentalserv.com in connection with this
     Agreement and the transactions contemplated hereby
     (including, without limitation, the fees and expenses of its
     advisors, accountants and legal counsel).

     7.4    Amendment. The Boards of Directors of the parties
            ---------
hereto may cause this Agreement to be amended at any time by
execution of an instrument in writing signed on behalf of each of
the parties hereto; provided that an amendment made subsequent to
adoption of the Agreement by the stockholders of Medpro shall not
(i) alter or change the amount or kind of consideration to be
received on conversion of Medpro Common Stock, (ii) alter or
change any term of the Articles of Incorporation of
Dentalserv.com to be effected by the Merger, or (iii) alter or
change any of the terms and conditions of the Agreement if such
alteration or change would materially adversely affect the
holders of Medpro Common Stock.

     7.5    Extension; Waiver. At any time prior to the Effective
            -----------------
Time any party hereto may, to the extent legally allowed, (i)
extend the time for the performance of any of the obligations or
other acts of the other parties hereto, (ii) waive any
inaccuracies in the representations and warranties made to such
party contained herein or in any document delivered pursuant
hereto and (iii) waive compliance with any of the agreements or
conditions for the benefit of such party contained herein. Any
agreement on the part of a party hereto to any such extension or
waiver shall be valid only if set forth in an instrument in
writing signed on behalf of such party.

                          ARTICLE VIII
                       GENERAL PROVISIONS
                       ------------------

     8.1   Non-Survival at Effective Time. The representations,
           ------------------------------
warranties and agreements set forth in this Agreement shall
terminate at the Effective Time, except that the agreements set
forth in Article I, Section 5.3 (Confidentiality), 5.8 (Form 8-K),
                    -----------                    ---
5.9 (Indemnification), 5.11 (Best Efforts and Further
---                    ----
Assurances), 7.3 (Expenses and Termination Fees), 7.4
             ---                                  ---
(Amendment), and this Article VIII shall survive the Effective Time.
                      ------------
     8.2    Notices. All notices and other communications
            -------
hereunder shall be in writing and shall be deemed given if
delivered personally or by commercial delivery service, or mailed
by registered or certified mail (return receipt requested) or
sent via facsimile (with confirmation of receipt) to the parties
at the following address (or at such other address for a party as
shall be specified by like notice):

          (a)  if to Medpro, to:

               Medpro Safety Products, Inc.
               817 Winchester Road

                                  25
<PAGE>

               Lexington, KY 40505
               Attention: Chief Executive Officer
               Facsimile No.: (859) 225-5347
               Telephone No.: (859) 225-5375

               with a copy (which shall not constitute notice to
               Medpro) to:

               Frost Brown Todd LLC
               250 West Main, Suite 2700
               Lexington, Kentucky
               Attention: Paul E. Sullivan, Esq.
               Facsimile No.: (859) 231-0011
               Telephone No.: (859) 231-0000

          (b)  if to Dentalserv.com, to:

               Dentalserv.com
               20 W. 55th Street
               5th Floor
               New York, NY 10010
               Tel. No.:(212) 849-8248
               Fax No.: (212) 867-1416

               with a copy (which shall not constitute notice to
               Dentalserv.com) to:

               Law Office of Eugene Michael Kennedy
               517 SW First Avenue
               Ft. Lauderdale, FL 33301
               Attn: Eugene Michael Kennedy, Esq.
               Tel. No.:  (954) 524-4155
               Fax No.:  (954) 525-4169

     8.3    Interpretation. When a reference is made in this
            --------------
Agreement to Exhibits or Schedules, such reference shall be to an
Exhibit or Schedule to this Agreement unless otherwise indicated.
The words "include," "includes" and "including" when used herein
shall be deemed in each case to be followed by the words "without
limitation." The phrase "made available" in this Agreement shall
mean that the information referred to has been made available if
requested by the party to whom such information is to be made
available. The phrases "the date of this Agreement", "the date
hereof", and terms of similar import, unless the context
otherwise requires, shall be deemed to refer to September 5,
2007. The table of contents and headings contained in this
Agreement are for reference purposes only and shall not affect in
any way the meaning or interpretation of this Agreement.

                                  26
<PAGE>

     8.4   Counterparts. This Agreement may be executed in one or
           ------------
more counterparts, including by facsimile, all of which shall be
considered one and the same agreement and shall become effective
when one or more counterparts have been signed by each of the
parties and delivered to the other parties, it being understood
that all parties need not sign the same counterpart.

     8.5   Entire Agreement; Nonassignability; Parties in
           ----------------------------------------------
Interest. This Agreement and the documents and instruments and
--------
other agreements specifically referred to herein or delivered
pursuant hereto, including the Exhibits, the Schedules, including
Dentalserv.com Disclosure Schedule and the Medpro Disclosure
Schedule (a) constitute the entire agreement among the parties
with respect to the subject matter hereof and supersede all prior
agreements and understandings, both written and oral, among the
parties with respect to the subject matter hereof.

     8.6   Severability. If any provision of this Agreement, or
           ------------
the application thereof, becomes or is declared by a court of
competent jurisdiction to be illegal, void or unenforceable, the
remainder of this Agreement will continue in full force and
effect and the application of such provision to other persons or
circumstances will be interpreted so as reasonably to effect the
intent of the parties hereto. The parties further agree to
replace such void or unenforceable provision of this Agreement
with a valid and enforceable provision that will achieve, to the
extent possible, the economic, business and other purposes of
such void or unenforceable provision.

     8.7    Remedies Cumulative. Except as otherwise provided
            -------------------
herein, any and all remedies herein expressly conferred upon a
party will be deemed cumulative with and not exclusive of any
other remedy conferred hereby, or by law or equity upon such
party, and the exercise by a party of any one remedy will not
preclude the exercise of any other remedy.

     8.8    Governing Law. This Agreement shall be governed by
            -------------
and construed in accordance with the laws of the State of
Delaware, without regard to the laws that might otherwise govern
under applicable principles of conflicts of law. Each of the
parties hereto irrevocably consents to the exclusive jurisdiction
of any court located within the State of New York in connection
with any matter based upon or arising out of this Agreement or
the matters contemplated herein, agrees that process may be
served upon them in any manner authorized by the laws of the
State of New York for such persons and waives and covenants not
to assert or plead any objection which they might otherwise have
to such jurisdiction and such process.

     8.9    Rules of Construction. The parties hereto agree that
            ---------------------
they have been represented by counsel during the negotiation,
preparation and execution of this Agreement and, therefore, waive
the application of any law, regulation, holding or rule of
construction providing that ambiguities in an agreement or other
document will be construed against the party drafting such
agreement or document.

                    [SIGNATURE PAGE FOLLOWS]

                                  27
<PAGE>

                 Merger Agreement Signature Page

     IN WITNESS WHEREOF, Medpro and Dentalserv.com have caused
this Agreement and Plan of Merger to be executed and delivered by
their respective officers thereunto duly authorized, all as of
the date first written above.

                                 DENTALSERV.COM

                                 By:__________________________

                                 _____________________________

                                 MEDPRO SAFETY PRODUCTS, INC.

                                 By:__________________________

                                  28
<PAGE>

                            Exhibit A
                            ---------

                      CERTIFICATE OF MERGER

                               Of

                  Medpro Safety Products, Inc.

                    (a Delaware corporation)

                          with and into

                         DENTALSERV.COM

                     (a Nevada corporation)

Under Section 78.416 of the Private Corporations law, Nevada Revised Statutes

  The undersigned corporation, Dentalserv.com, hereby certifies that:

          FIRST:    The name and state of incorporation of each
of the constituent corporations is: Medpro Safety Products, Inc.,
a Delaware corporation (the "Disappearing Corporation"), and
                             ------------------------
Dentalserv.com, a Nevada corporation (the "Surviving Corporation").
                                           ---------------------
          SECOND:   An agreement of merger has been approved,
adopted, certified, executed and acknowledged by the Disappearing
Corporation and by the Surviving Corporation in accordance with
the provisions of the Private Corporations law, Nevada Revised
Statues.

          THIRD:   The name of the Surviving Corporation is
Dentalserv.com.

          FOURTH:  The Amended and Restated Articles of
Incorporation, in the form of attached Exhibit A, shall be the
                                       ---------
Articles of Incorporation of the Surviving Corporation, which
shall change its name to Medpro Safety Products, Inc. upon the
effectiveness of this Certificate.

          FIFTH:   The executed agreement of merger is on file at
the principal place of business of the Surviving Corporation at:

                  Dentalserv.com
                  20 W. 55th Street
                  5th Floor
                  New York, NY 10010

          SIXTH:   A copy of the agreement of merger will be
furnished by the Surviving Corporation on request, and without
cost, to any stockholder of the Disappearing Corporation or the
Surviving Corporation.

          SEVENTH:  This Certificate of Merger will be effective
at 5:00 p.m. Eastern Time on _________, 2007.

                                  29
<PAGE>

     IN WITNESS WHEREOF, the undersigned has executed and
subscribed to this Certificate of Merger on behalf of
Dentalserv.com as its authorized officer and hereby affirms,
under penalties of perjury, that this Certificate of Merger is
the act and deed of such corporation and that the facts stated
herein are true.

     DATED: October ___, 2007

                                  Dentalserv.com
                                  _____________________________
                                  a Nevada corporation

                                  By:___________________________
                                     Dr. Lawrence Chimerine,
                                     Chief Executive Officer

__________________________________________________________________

                                  30
<PAGE>

                            Exhibit B
                            ---------
                                                        EXHIBIT A

                      AMENDED AND RESTATED

                    ARTICLES OF INCORPORATION

                               OF

                         DENTALSERV.COM

DENTALSERV.COM, a Nevada corporation (the "Corporation"), does
hereby certify that:

FIRST:    The original articles of incorporation of the
Corporation were filed with the Secretary of State of the Nevada
on December 15, 1999 (the "Original Articles of Incorporation").

SECOND:   That the Board of Directors of the Corporation, by
unanimous written consent dated as of August 13, 2007, adopted
resolutions setting forth proposed amendments to the Original
Articles of Incorporation, declaring such amendments to be
advisable and calling for the submission of such amendments to
the stockholders of the Corporation for consideration thereof.

THIRD:   That  thereafter, pursuant to Section 78.320 of the
Private Corporations law, Nevada Revised  Statutes, written
consents approving the amendments set forth above were signed by
holders of outstanding voting stock having not less than the
minimum  number of votes that would be necessary to authorize or
take such action at a meeting on such date at which all shares
entitled to vote thereon were present and voted.

FOURTH:   That  said amendments were duly adopted in accordance
with the provisions of Sections 78.1955, 78.2055, 78.315 & 78.320
of the Private Corporations law, Nevada Revised Statutes.

FIFTH:   That the capital of the Corporation shall not be reduced
under or by reason of said amendments.

SIXTH:  The Original Articles of Incorporation of the Corporation
are hereby amended and restated to read in full as follows:

ARTICLE I  NAME

The name of this corporation is Medpro Safety Products, Inc.

ARTICLE II PURPOSES

The purpose, object and nature of the business for which this
corporation is organized are:

                                  31
<PAGE>

(a)  to engage in any lawful activity; and

(b)  to carry on such business as may be necessary, convenient,
     or desirable to accomplish the above purposes, and to do all
     other things incidental thereto which are not forbidden by
     law or by these Articles of Incorporation.

ARTICLE III    DURATION

The corporation will have perpetual existence.

ARTICLE IV POWERS

The powers of the corporation will be those powers granted by
78.060 and 78.070 of the Nevada Revised Statutes under which this
corporation is formed.  In addition, the corporation will have
the following specific powers:

(a)  To elect or appoint officers and agents of the corporation
     and fix their compensation;

(b)  To act as an agent for any individual, association,
     partnership, corporation, or other legal entity;

(c)  To receive, acquire, hold, exercise rights arising out of
     the ownership or possession thereof, sell, or otherwise
     dispose of, shares or other interests in, or obligations of,
     individuals, associations, partnerships, corporations, or
     governments;

(d)  To receive, acquire, hold, pledge, transfer, or otherwise
     dispose of shares purchased, directly or indirectly, out of
     earned surplus;

(e)  To make gifts or contributions for the public welfare or for
     charitable, scientific or educational purposes.

ARTICLE V  AUTHORIZED CAPITAL STOCK

(a)   The total number of shares which the Corporation shall have
authority to issue is  One  Hundred  Million (100,000,000),
consisting of Ninety Million (90,000,000) shares of Common Stock,
par  value  $0.001  per share,  (hereafter called  the "Common
Stock"), and Ten Million (10,000,000) shares of Preferred Stock,
par value  $0.01 per share, (hereinafter called  the  "Preferred
Stock")

(b)   Each four (4) shares of Common Stock outstanding at 5:00
p.m. on August 10, 2007, shall be deemed to be one (1) share of
Common Stock of the Corporation, par value $0.001 per share.

(c)  Shares of Preferred Stock may be issued from time to time in
one or more series as may be established from time to time by
resolution of the Board of Directors of the Corporation
(hereinafter the "Board"), each of which series shall consist of
such number of shares and have such distinctive designations or
title as shall be fixed by resolution of the Board prior to the
issuance of any shares of such series. Each such class or series
of Preferred Stock shall have such voting powers, full or
limited, or no voting powers, and such preferences and relative,

                                  32
<PAGE>

participating, optional or other special rights and such
qualifications, limitations or restrictions thereof, as shall be
stated in such resolution of the Board providing for the
issuances of such series of Preferred Stock.

ARTICLE VI DIRECTORS

Section 1.     Size of Board.  The number of directors of this
corporation may consist of from one (1) to nine (9) directors, as
determined, from time to time, by the then existing Board of
Directors.  Their qualifications, terms of office, manner of
election, time and place of meeting, and powers and duties will
be such as are prescribed by statute and in the bylaws of the
corporation.

Section 2.     Powers of Board.  In furtherance and not in
limitation of the powers conferred by the laws of the State of
Nevada, the Board of Directors is expressly authorized and
empowered:

(a)  To make, alter, amend and repeal the bylaws subject to the
     power of the shareholders to alter or repeal the bylaws made
     by the Board of Directors;

(b)  Subject to the applicable provisions of the bylaws then in
     effect, to determine, from time to time, whether and to what
     extent, and at what times and places, and under what
     conditions and regulations, the account and books of the
     corporation, or any of them, will be open to shareholder
     inspection.  No shareholder will have any right to inspect
     any of the accounts, books or documents of the corporation,
     except as permitted by law, unless and until authorized to
     do so by resolution of the Board of Directors or of the
     shareholders of the corporation;

(c)  To issue stock of the corporation for consideration of any
     tangible or intangible property or benefit to the
     corporation including, but not limited to, cash, promissory
     notes, services performed, or for any other assets of value
     in accordance with the action of the Board of Directors
     without vote or consent of the shareholders and the judgment
     of the Board of Directors as to value received and in return
     therefore will be conclusive and said stock when issued will
     be fully paid and non-assessable;

(d)  To authorize and issue, without shareholder consent,
     obligations of the corporation, secured and unsecured, under
     such terms and conditions as the Board, in its sole
     discretion, may determine, and to pledge or mortgage, as
     security therefore, any real or personal property of the
     corporation, including after acquired property;

(e)  To determine whether any and if so what part of the earned
     surplus of the corporation will be paid in dividends to the
     shareholders, and to direct and determine other use and
     disposition of such earned surplus;

(f)  To fix, from time to time, the amount of the profits of the
     corporation to be reserved as working capital or for any
     other lawful purpose;

(g)  To establish bonus, profit-sharing, stock option or other types
     of incentive compensation plans for the employees, including
     officers and directors, of the corporation and to fix the

                                  33
<PAGE>

     amount of profits to be shared and distributed, and
     to determine the persons to participate in any such plans
     and the amount of their respective participations;

(h)  To designate, by resolution or resolutions passed by a
     majority of the whole Board, one or more committees, each
     consisting of two or more directors, which to the extent
     permitted by law and authorized by the resolution of the
     bylaws will have and may exercise the powers of the Board;

(i)  To provide for the reasonable compensation of its own
     members by bylaws, and to fix the terms and conditions upon
     which such compensation will be paid;

(j)  In addition to the powers and authority herein before, or by
     statute, expressly conferred upon it, the Board of Directors
     may exercise all such powers and do all such acts and things
     as may be exercised or done by the corporation, subject,
     nevertheless, to the provisions of the laws of the State of
     Nevada, of these Articles of Incorporation, and of the
     bylaws of the corporation.

Section 3.     Interested Directors.  No contract or transaction
between this corporation and any of its directors, or between
this corporation and any other corporation, firm, association, or
other legal entity will be invalidated by reason of the fact that
the director of the corporation has a direct or indirect
interest, pecuniary or otherwise, in such corporation, firm or
association, or legal entity, or because the interested director
was present at the meeting of the Board of Directors which acted
upon or in reference to such contract or transaction, or because
he participated in such action, provided that (1) the interest of
each such director will have been disclosed to or known by the
Board and a disinterested majority of the Board will have
nonetheless ratified and approved such contract or transaction
(such interested director or directors may be counted in
determining whether a quorum is present for the meeting at which
such ratification or approval is given); or (2) the conditions of
N.R.S. 78.144 are met.

ARTICLE VII    LIMITATION OF LIABILITY OF OFFICERS OR DIRECTORS

     The personal liability of a director or officer of the
corporation to the corporation or the shareholders for damages
for breach of fiduciary duty as a director or officer will be
limited to acts or omissions which involve intentional
misconduct, fraud or a knowing violation of law.

ARTICLE VIII   INDEMNIFICATION

Each director and each officer of the corporation may be
indemnified by the corporation as follows:

(a)  The corporation may indemnify any person who was or is a
     party, or is threatened to be made a party, to any
     threatened, pending or completed action or suit or
     proceeding, whether civil, criminal, administrative or
     investigative (other than an action by or in the right of
     the corporation), by reason of the fact that he is or was a
     director, officer, employee or agent of the corporation or
     is or was serving at the request of the corporation as a
     director, officer, employee, or agent of the corporation,
     partnership, joint venture, trust or other enterprise,
     against expenses (including attorney's fees), judgments,
     fines and amounts paid in settlement, actually and
     reasonably incurred by him in connection

                                  34
<PAGE>

     with the action, suit or proceeding, if he acted in good faith and
     in a manner which he reasonably believed to be in or not opposed
     to the best interests of the corporation and with respect to
     any criminal action or proceeding, had no reasonable cause
     to believe his conduct was unlawful.  The termination of any
     action, suit or proceeding, by judgment, order, settlement,
     conviction or upon plea of nolo contendere or its equivalent
     does not itself create a presumption that the person did not
     act in good faith and in a manner in which he reasonably
     believed to be in or not opposed to the best interests of
     the corporation, and that, with respect to any criminal
     action or proceeding, he had reasonable cause to believe
     that his conduct was lawful.

(b)  The corporation may indemnify any person who was or is a
     party, or is threatened to be made a party, to any
     threatened, pending or completed action or suit by or in the
     right of the corporation, to procure a judgment in its favor
     by reason of the fact that he is or was a director, officer,
     employee or agent of the corporation, or is or was serving
     at the request of the corporation as a director, officer,
     employee or agent of the corporation, partnership, joint
     venture, trust or other enterprise, against expenses
     including amounts paid in settlement and attorney's fees
     actually and reasonably incurred by him in connection with
     the defense or settlement of the action or suit, if he acted
     in good faith and in a manner which he reasonably believed
     to be in or not opposed to the best interest of the
     corporation.  Indemnification may not be made for any claim,
     issue or matter as to which such a person has been adjudged
     by a court of competent jurisdiction, after exhaustion of
     all appeals there from, to be liable to the corporation or
     for amounts paid in settlement to the corporation, unless
     and only to the extent that the court in which the action or
     suit was brought or other court of competent jurisdiction
     determines upon application that in view of all the
     circumstances of the case the person is fairly and
     reasonably entitled to indemnity for such expenses as the
     court deems proper.

(c)  To the extent that a director, officer or employee or agent
     of the corporation has been successful on the merits or
     otherwise in defense of any action, suit or proceeding
     referred to in subsections (a) and (b) of this Article, or
     in defense of any claim, issue or matter therein, he must be
     indemnified by the corporation against expenses, including
     attorney's fees, actually and reasonable incurred by him in
     connection with the defense.

(d)  Any indemnification under subsection (a) and (b) unless
     ordered by a court or advanced pursuant to subsection (e),
     must be made by the corporation only as authorized in the
     specific case upon determination that indemnification of the
     director, officer, employee or agent is proper in the
     circumstances.  The determination must be made:

     By the stockholders;

     (i)  By the Board of Directors by majority vote of a quorum
          consisting of directors who were not parties to the
          act, suit or proceeding;

     (ii) If a majority vote of a quorum consisting of directors
          who were not parties to the act, suit or proceeding so
          orders, by independent legal counsel in a written
          opinion; or

                             35
<PAGE>

     (iii) If a quorum consisting of directors who were not
          parties to the act, suit or proceeding cannot be
          obtained, by independent legal counsel in a written
          opinion.

(e)  Expenses of officers and directors incurred in defending a
     civil or criminal action, suit or proceeding must be paid by
     the corporation as they are incurred and in advance of the
     final disposition of the action, suit or proceeding, upon
     receipt of an undertaking by or on behalf of the director or
     officer to repay the amount if it is ultimately determined
     by a court of competent jurisdiction that he is not entitled
     to be indemnified by the corporation.  The provisions of
     this subsection do not affect any rights to advancement of
     expenses to which corporate personnel other than directors
     or officers may be entitled under any contract or otherwise
     by law.

(f)  The indemnification and advancement of expenses authorized
     in or ordered by a court pursuant to this section:

     (i)  Does not exclude any other rights to which a person
          seeking indemnification or advancement of expenses may
          be entitled under the certificate or Articles of
          Incorporation or any bylaw, agreement, vote of
          stockholders or disinterested directors or otherwise,
          for either an action in his official capacity or an
          action in another capacity while holding his office,
          except that indemnification, unless ordered by a court
          pursuant to subsection (b) or for the advancement of
          expenses made pursuant to subsection (e) may not be
          made to or on behalf of any director or officer if a
          final adjudication established that his acts or
          omissions involved intentional misconduct, fraud or a
          knowing violation of the law and was material to the
          cause of action.

     (ii) Continues for a person who has ceased to be a director,
          officer, employee or agent and inures to the benefit of
          the heirs, executors and administrators of such a
          person.

ARTICLE IX     PLACE OF MEETING; CORPORATE RECORD BOOKS

Subject to the laws of the State of Nevada, the shareholders and
the directors will have the power to hold their meeting, and the
directors will have the power to have an office or offices and to
maintain the books of the corporation outside the State of
Nevada, at such place or places as may from time to time be
designated in the bylaws or by appropriate resolution.

ARTICLE X  AMENDMENT OF ARTICLES

The provision of these articles of incorporation may be amended,
altered or repealed from time to time to the extent and manner
prescribed by the laws of the State of Nevada, and additional
provisions authorized by such laws as are then in force maybe
added.  All rights herein conferred on the directors, officers
and shareholders are granted subject to reservation.

                                  36
<PAGE>

 Dentalserv.com
_______________________________________________________________
a Nevada corporation

By:____________________________________________________________
   Name:
   Title:

                                  37
<PAGE>

                  AGREEMENT AND PLAN OF MERGER

                             BETWEEN

                  MEDPRO SAFETY PRODUCTS, INC.

                               AND

                         DENTALSERV.COM

                        September 5, 2007
______________________________________________________________________

                                  38
<PAGE>

                        Table of Contents

                                                                   Page
                                                                   ----

ARTICLE I THE MERGER                                                 1

  1.1     The Merger                                                 1

  1.2     Closing; Effective Time                                    1

  1.3     Effect of the Merger                                       2

  1.4     Conversion of MedPro Common Stock                          2

  1.5     Surrender of Certificates                                  2

  1.6     No Further Ownership Rights in Medpro Common Stock         3

  1.7     Lost, Stolen or Destroyed Certificates                     3

  1.8     Tax Consequences                                           4

  1.9     Withholding Rights                                         4

  1.10    Taking of Necessary Action; Further Action                 4

ARTICLE II REPRESENTATIONS AND WARRANTIES OF DENTALSERV.COM          4

  2.1     Organization, Standing and Power                           4

  2.2     Capital Structure                                          5

  2.3     Authority                                                  5

  2.4     Financial Statements                                       6

  2.5     Absence of Certain Changes                                 6

  2.6     Absence of Undisclosed Liabilities                         7

  2.7     Litigation                                                 7

  2.8     Restrictions on Business Activities                        7

  2.9     Governmental Authorization                                 7

  2.10    Title to Property                                          7

                                  39
<PAGE>

                                                                   Page
                                                                   ----

  2.11    Intellectual Property                                      7

  2.12    Taxes                                                      8

  2.13    Labor Matters                                              8

  2.14    Compliance With Laws                                       8

  2.15    Minute Books                                               8

  2.16    Brokers' and Finders' Fees                                 8

  2.17    Vote Required                                              8

  2.18    Board Approval                                             9

  2.19    Over-the-Counter Bulletin Board Quotation                  9

  2.20    Representations Complete                                   9

ARTICLE III REPRESENTATIONS AND WARRANTIES OF MEDPRO                 9

  3.1     Organization, Standing and Power                           9

  3.2     Capital Structure                                         10

  3.3     Authority                                                 10

  3.4     Financial Statements                                      11

  3.5     Absence of Certain Changes                                11

  3.6     Absence of Undisclosed Liabilities                        11

  3.7     Litigation                                                12

  3.8     Restrictions on Business Activities                       12

                                  40
<PAGE>

                                                                   Page
                                                                   ----
  3.9     Taxes                                                     12

  3.10    Labor Matters                                             13

  3.11    Intellectual Property                                     13

  3.12    Interested Party Transactions                             13

  3.13    Compliance With Laws                                      13

  3.14    Broker's and Finders' Fees                                13

  3.15    Minute Books                                              14

  3.16    Vote Required                                             14

  3.17    Board Approval                                            14

  3.18    Representations Complete                                  14

ARTICLE IV  CONDUCT PRIOR TO THE EFFECTIVE TIME                     14

  4.1     Conduct of Business                                       14

  4.2     Restrictions on Conduct of Business                       15

ARTICLE V ADDITIONAL AGREEMENTS                                     17

  5.1     Effectiveness of Merger                                   17

  5.2     Access to Information                                     17

  5.3     Confidential Information; Non-Solicitation or Negotiation 17

  5.4     Public Disclosure                                         18

  5.5     Consents                                                  18

  5.6     Legal Requirements                                        19

                                  41
<PAGE>

  5.7     Blue Sky Laws                                             19

  5.8     Form 8-K                                                  19

  5.9     Indemnification                                           19

  5.10    Tax Treatment                                             20

  5.11    Best Efforts and Further Assurances                       21

ARTICLE VI CONDITIONS TO THE MERGER                                 21

  6.1     Conditions to Obligations of Each Party to Effect         21
          the Merger

  6.2     Additional Conditions to Obligations of Dentalserv.com    21

  6.3     Additional Conditions to the Obligations of Medpro        22

ARTICLE VII TERMINATION, AMENDMENT AND WAIVER                       23

  7.1     Termination                                               23

  7.2     Effect of Termination                                     24

  7.3     Expenses and Termination Fees                             24

  7.4     Amendment                                                 25

  7.5     Extension; Waiver                                         25

ARTICLE VIII GENERAL PROVISIONS                                     25

  8.1     Non-Survival at Effective Time                            25

  8.2     Notices                                                   25

  8.3     Interpretation                                            26

  8.4     Counterparts                                              27

  8.5     Entire Agreement; Nonassignability; Parties in Interest   27

                                  42
<PAGE>

  8.6     Severability                                              27

  8.7     Remedies Cumulative                                       27

  8.8     Governing Law                                             27

  8.9     Rules of Construction                                     27

______________________________________________________________________

                        TABLE OF CONTENTS
                        -----------------

EXHIBITS

A - Certificate of Merger

B- Amended and Restated Articles of Incorporation

SCHEDULES
---------

Dentalserv.com Disclosure Schedule
Medpro Disclosure Schedule

_____________________________________________________________________

                                  44
<PAGE>Amended and Restated Registration Rights Agreement

 

Exhibit 10.4

 

AMENDED AND RESTATED

REGISTRATION RIGHTS AGREEMENT

BY AND AMONG

LULULEMON CORP.

AND

THE HOLDERS LISTED ON SCHEDULES A AND B HERETO

Dated as of July 26, 2007

 

 

 

AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

     This amended and restated Registration Rights Agreement (this “Agreement”) is
entered into as of July 26, 2007 by and among:

	•	 	Lululemon Corp., a Delaware corporation (the “Company”);
	 
	•	 	each of the stockholders of the Company’s common stock, par value $0.01 per
share (“Common Stock”), whose names and addresses are set forth under
Schedule A (the “A Holders”); and
	 
	•	 	each of the stockholders of Common Stock, whose names and addresses are set
forth under Schedule B (the “B Holders”).

BACKGROUND

     On April 26, 2007, the Company, its stockholders and certain other parties entered into an
Agreement and Plan of Reorganization (the “Agreement and Plan of Reorganization”) pursuant
to which all of the Company’s outstanding capital stock was reclassified by conversion into shares
of Common Stock (the “Reorganization”).

     The Company previously granted certain of its stockholders registration rights as described in
that certain Registration Rights Agreement, dated December 5, 2005, between the Company and such
stockholders (the “Prior Registration Rights Agreement”). In connection with the
Reorganization, the Company and the stockholders party to the Prior Registration Rights Agreement
desire to amend and restate the Prior Registration Rights Agreement as provided herein.

AGREEMENT

     NOW, THEREFORE, in consideration of the foregoing, and for other good and valuable
consideration, the receipt and sufficiency of which hereby is acknowledged, the parties agree as
follows:

ARTICLE 1

RULES OF CONSTRUCTION AND DEFINITIONS

          Section 1.1 Rules of Construction. In this Agreement, unless otherwise specified or where the context otherwise requires:

               (a) the headings of particular provisions of this Agreement are inserted for convenience only
and will not be construed as a part of this Agreement or serve as a limitation or expansion of the
scope of any term or provision of this Agreement;

               (b) words importing the singular only shall include the plural and vice versa;

               (c) words importing any gender shall include other genders;

               (d) the words “include,” “includes” or “including” shall be deemed followed by the words
“without limitation”;

               (e) the words “hereof,” “herein” and “herewith” and words of similar import, shall, unless
otherwise stated, be construed to refer to this Agreement as a whole and not to any particular
provision of this Agreement;

-2-

 

               (f) unless otherwise specified, the term “days” shall mean calendar days;

               (g) a “percentage” (or a “majority”) of the Registrable Securities (or, where applicable, any
class of securities) shall be determined based on the number of shares of such securities; and

               (h) unless otherwise provided, the currency for all dollar figures included in this Agreement
shall be the US Dollar.

          Section 1.2 Defined Terms. As used in this Agreement, the following terms shall have the following meanings:

     “Advent” means Advent International Corporation, a Delaware corporation.

     “Advent Funds” has the meaning set forth in the Company Stockholders Agreement.

     “Adverse Disclosure” means public disclosure of non-public information relating to a
material proposed acquisition, disposition, financing, reorganization, recapitalization or similar
transaction involving the Company or one of its Affiliates, which disclosure in the good faith
judgment of the Board of Directors, after consultation with external legal counsel, (a) would be
required to be made in any Registration Statement so that such Registration Statement would not be
materially misleading, (b) would not be required to be made at such time but for the filing,
effectiveness or continued use of such Registration Statement and (c) would have a material adverse
effect on the Company or its business or on the Company’s ability to effect such material proposed
acquisition, disposition, financing, reorganization, recapitalization or similar transaction.

     “Adversely Affected Holder” has the meaning set forth in Section 3.6(a).

     “Affiliate” means, as to any specified Person, (a) any other person controlling,
controlled by or under common control with such specified Person, (b) any other Person of which
such specified Person is an officer, employee, agent, director, shareholder or partner or (c) any
member of the Family Group of such specified Person or of any individual who is an Affiliate of
such specified Person by reason of clause (a) of this definition; provided, however, that no Person
shall be deemed an Affiliate of any other Person solely by reason of any investment in the Company
or the Lululemon Group. The term “control,” with respect to any Person, means possession,
direct or indirect, of the power to direct or cause the direction of the management and policies of
such Person, whether through the ownership of voting securities or a partnership interest, by
contract or otherwise. With respect to each of the Institutional Holders, the term “Affiliate”
shall also include (i) any entity in which such Institutional Holder (or one of its Affiliates) is
a general partner or member, and (ii) each investor in such Institutional Holder, but only in
connection with the liquidation, winding up or dissolution of the Institutional Holder, and only to
the extent of such investor’s pro rata share in the Institutional Investor. With respect to each
Advent Fund, the term “Affiliate” shall also include any investment fund managed by Advent.

     “Aggregate Offering Price” means the aggregate offering price of Registrable
Securities in any offering, calculated based upon the Fair Market Value of the Registrable
Securities, in the case of a Minimum Demand Amount, as of the date that the applicable Request is
delivered, and in the case of a Shelf Underwritten Offering, as of the date that the applicable
Underwriting Notice is delivered.

     “Agreement” has the meaning set forth in the preamble.

     “Amendment” has the meaning set forth in Section 3.6(a).

-3-

 

     “Beneficial Owner” and “beneficially own” shall be determined in accordance
with Rule 13d-3 promulgated under the Exchange Act.

     “Board of Directors” means the Company’s board of directors.

     “Business Day” shall mean any day other than (i) a Saturday or Sunday or (ii) a day on
which banks in New York, New York are required or authorized by law, executive order or
governmental decree to be closed.

     “Certificate of Incorporation” means the Certificate of Incorporation of the Company,
as filed with the Delaware Secretary of State, including, without limitation, any certificate of
designations filed therewith relating to any class or series of capital stock of the Company, as
further amended or supplement from time to time in accordance with the terms thereof.

     “Common Stock” has the meaning set forth in the recitals.

     “Company” has the meaning set forth in the preamble and shall include the Company’s
successors by merger, acquisition, reorganization or otherwise.

     “Company Stockholders Agreement” means the Stockholders Agreement by and among the
Company and the Persons listed therein, dated as of the date hereof, as amended from time to time
in accordance with the terms therein, relating to the capital stock, governance and affairs of the
Company.

     “Counterpart Signature Page” means a counterpart signature page to this Agreement in
substantially the same form of Schedule C.

     “Cutback Notice” has the meaning set forth in Section 2.1(h)(5).

     “Demand Participation Notice” has the meaning set forth in Section 2.1(d).

     “Demand Registration” has the meaning set forth in Section 2.1(a).

     “Demand Right” has the meaning set forth in Section 2.1(a).

     “Exchange Act” means the Securities Exchange Act of 1934, as amended, and any
successor thereto, and any rules and regulations promulgated thereunder, all as the same shall be
in effect from time to time.

     “Fair Market Value” means, with respect to any Registrable Securities, (a) if the
Registrable Securities trade on a stock exchange or trading mechanism which publishes the closing
sales price of the Registrable Securities, the average closing sales price, calculated for the five
(5) trading days immediately preceding the date of a determination, (b) if the Registrable
Securities trade on a stock exchange or trading mechanism which does not publish the closing sales
price of the Registrable Securities, then the average of the bid and ask prices, calculated for the
five (5) trading days immediately preceding the date of a determination; or (c) in all other cases
the price determined in good faith by the board of directors of the Company.

     “Holder” means any holder or holders of Registrable Securities who is a party to this
Agreement or who otherwise agrees in writing to be bound by the provisions of this Agreement
pursuant to Section 3.3.

     “Incidental Cutback Notice” has the meaning set forth in Section 2.2(b).

-4-

 

     “Incidental Registration” means any registration of the Registrable Securities of a
Holder pursuant to Section 2.2(a), but shall exclude any registration which constitutes a Demand
Registration, Shelf Underwritten Offering or non-underwritten offering under a Shelf Registration
Statement.

     “Incidental Registration Notice” has the meaning set forth in Section 2.2(a)(1).

     “Indemnified Person” has the meaning set forth in Section 2.7(a).

     “Initiating Holders” means the Holder or Holders who made the Request to initiate a
Demand Registration, together with all Affiliates of such Holder or Holders.

     “Institutional Holders” has the meaning set forth in the Company Stockholders
Agreement.

     “Loss” or “Losses” has the meaning set forth in Section 2.7(a).

     “Minimum Demand Amount” means an amount of Registrable Securities that either (i) is
equal to or greater than 500,000 shares of Common Stock (as such number may be adjusted hereafter
to reflect any stock dividend, subdivision, recapitalization, reclassification, split,
distribution, combination or similar event) or (ii) has an Aggregate Offering Price of at least $5
million.

     “NASD” means the National Association of Securities Dealers, Inc.

     “NASDAQ” means The Nasdaq Stock Market, Inc.

     “Non-Underwritten Period” means, with respect to any offering which is not a Shelf
Registration and which does not contemplate an Underwritten Offering, a period of not less than 180
days (or such shorter period as will terminate when all Registrable Securities covered by such
Registration Statement have been sold or withdrawn).

     “Participating Holder” means any Holder exercising its right to participate in a
Demand Registration under Section 2.1(d).

     “Person” or “person” means any individual, firm, limited liability company,
partnership, joint venture, corporation, joint stock company, trust or unincorporated organization,
incorporated or unincorporated association, government (or any department, agency or political
subdivision thereof) or other entity of any kind.

     “Permitted Transferee” has the meaning set forth in the Stockholders Agreement.

     “Preferred Stock” has the meaning set forth in the recitals.

     “Prospectus” means the prospectus included in any Registration Statement, all
amendments and supplements to such prospectus and all material incorporated by reference in such
prospectus.

     “Registrable Securities” means (a) shares of Common Stock acquired pursuant to the
Agreement and Plan of Reorganization, (b) shares of Common Stock acquired upon the exchange of
exchangeable shares issued by Lululemon Canadian Holding, Inc., a company formed under the laws of
British Columbia and (c) any shares of Common Stock that may be issued or distributed by way of stock
dividend, stock split or other distribution, merger, consolidation, exchange offer,
recapitalization or reclassification or similar transaction, or exercise or conversion of any of
the foregoing; provided, however, that any of the foregoing securities shall cease to be
“Registrable Securities” (x) to the extent that a Registration Statement with respect to their sale
has been declared effective under the Securities

-5-

 

Act and they have been disposed of pursuant to
such Registration Statement, (y) to the extent that they have been distributed pursuant to Rule 144
or Rule 145 (or any similar provisions then in force) under the Securities Act, or (z) at any time
after the ten (10) year anniversary of the date hereof, to the extent that they are eligible for
resale without registration by the Holder thereof under paragraph (k) of Rule 144 (or any similar
provision then in force) under the Securities Act.

     “registration” means a registration of the Company’s securities for sale to the public
under a Registration Statement.

     “Registration Period” means either the Shelf Period, the Underwritten Period or the
Non-Underwritten Period, as applicable.

     “Registration Statement” means any registration statement of the Company filed with,
or to be filed with, the SEC under the Securities Act, including the Prospectus, amendments,
supplements and post-effective amendments to such registration statement, and all exhibits to, and
all material incorporated by reference in, such registration statement.

     “Request” has the meaning set forth in Section 2.1(c).

     “SEC” means the Securities and Exchange Commission, or any successor U.S. governmental
agency.

     “Securities Act” means the Securities Act of 1933, as amended, and any successor
thereto, and any rules and regulations promulgated thereunder, all as the same shall be in effect
from time to time.

     “Shelf Demand” has the meaning set forth in Section 2.1(b).

     “Shelf Period” means, with respect to any Shelf Registration Statement (other than a
Shelf Underwritten Offering), a period of thirty-six (36) consecutive months (or such shorter
period as will terminate when all Registrable Securities covered by such Registration Statement
have been sold or withdrawn) plus the period of time, if any, during which use of such Shelf
Registration Statement has been suspended pursuant to Section 2.1(g).

     “Shelf Registration” means a registration effected pursuant to a Shelf Demand.

     “Shelf Registration Statement” means a Registration Statement of the Company filed
with the SEC on Form S-3 (or any successor form or other appropriate form under the Securities Act)
for an offering to be made on a continuous or delayed basis pursuant to Rule 415 under the
Securities Act (or any similar rule that may be adopted by the SEC) covering the Registrable
Securities.

     “Shelf Underwritten Offering” means an Underwritten Offering of Registrable Securities
by a Holder pursuant to a take down from a Shelf Registration Statement in accordance with Section
2.1(h)(2).

     “Similar Securities” means, in connection with any registration of securities of the
Issuer, all securities of the Issuer which are (i) the same as or similar to those being
registered, (ii) convertible into or exchangeable or exercisable for the securities being
registered, or (iii) the same as or similar to the securities into which the securities being
registered are convertible into, exchangeable or exercisable for.

     “Target Registration” means a Registration Statement filed pursuant to an obligation
incurred by the Company in connection with an acquisition of the stock or assets of another
company.

-6-

 

     “Underwritten Offering” means a registration in which securities of the Company are
sold by the Company or a Holder to an underwriter or underwriters on a firm commitment basis for
reoffering to the public, including a Shelf Underwritten Offering.

     “Underwritten Period” means, with respect to any offering which is an Underwritten
Offering (including a Shelf Underwritten Offering), a period of not less than 180 days plus such
longer period (not to exceed 90 days after such 180th day) as, in the opinion of counsel for the
underwriter or underwriters, is required by law for the delivery of a Prospectus in connection with
the sale of Registrable Securities by an underwriter or dealer.

     “Underwriting Notice” has the meaning set forth in Section 2.1(h).

     “Underwriter Cutback Condition” has the meaning set forth in Section 2.2(b).

ARTICLE 2

REGISTRATION RIGHTS

          Section 2.1 Demand Registrations.

               (a) Demand by A Holders and B Holders. At any time, or from time to time, following
the 180th day after the Company has become subject to the periodic reporting
requirements of the Exchange Act, (i) the A Holders who beneficially own a majority of the
outstanding Registrable Securities beneficially owned by all A Holders or (ii) the B Holders who
beneficially own a majority of the outstanding Registrable Securities beneficially owned by all B
Holders, shall have the right to require the Company to register all or part of the Registrable
Securities under the Securities Act (each such right, a “Demand Right”); provided, that
each registration made pursuant to a Demand Right must include Registrable Securities in an amount
not less than the Minimum Demand Amount. The Company shall file with the SEC, as expeditiously as
reasonably possible after the initiation of a Demand Right, a Registration Statement relating to
the offer and sale of the Registrable Securities requested to be included therein by the Holders
thereof (each, a “Demand Registration”) in accordance with the methods of distribution
elected by such Holders and shall use its best efforts to cause such Registration Statement to be
declared effective under the Securities Act as expeditiously as reasonably possible thereafter.
The Company shall use its best efforts to keep the Registration Statement relating to such Demand
Registration continuously effective in order to permit the Prospectus forming a part thereof to be
usable by the Holders, the underwriters and any brokers or dealers during the period set forth in
Section 2.1(f). In no event shall (i) the A Holders have the right to require the Company to
effect more than three (3) Demand Registrations pursuant to this Agreement or (ii) the B Holders,
have the right to require the Company to effect more than three (3) Demand Registrations pursuant
to this Agreement, including, in the case of each of clause (i) and (ii) of this sentence, Demand
Registrations which are Shelf Demands as set forth in Section 2.1(b). A registration shall not be
counted as “effected” for purposes of this Section 2.1 until such time as the applicable
registration statement has been declared effective by the SEC, unless the Initiating Holders
withdraw their request for such registration, elect not to pay the registration expenses therefor,
and forfeit their right to one demand registration statement pursuant to Section 2.6, in which case
such withdrawn registration statement shall be counted as “effected” for purposes of this Section
2.1.

               (b) Shelf Registrations. The Initiating Holders shall have the right, at any time
that the Company is legally eligible to file a Shelf Registration Statement, to elect that a Demand
Registration be made pursuant to a Shelf Registration Statement (a “Shelf Demand”);
provided, that each
registration made pursuant to a Shelf Demand must include Registrable Securities in an amount
not less than the Minimum Demand Amount. If the Company shall receive a Request specifying a Shelf
Demand,

-7-

 

the Company shall file with the SEC, as expeditiously as reasonably possible after the
initiation of a Shelf Demand, a Shelf Registration Statement relating to the offer and sale of the
Registrable Securities requested to be included therein by the Holders thereof from time to time in
accordance with the methods of distribution elected by such Holders and shall use its best efforts
to cause such Shelf Registration Statement to be declared effective under the Securities Act as
expeditiously as reasonably possible thereafter. The Company shall use its best efforts to keep
the Shelf Registration Statement continuously effective in order to permit the Prospectus forming a
part thereof to be usable by the Holders, the underwriters and any brokers or dealers during the
period set forth in Section 2.1(f).

               (c) Demand Notice. All requests to initiate a Demand Right must be made by notice (a
“Request”):

                         (1) provided to the Company in writing;

                         (2) stating that it is a notice to initiate Demand Rights under this Agreement;

                         (3) stating whether a Shelf Demand is being requested;

                         (4) identifying the Holder(s) effecting the request; and

                         (5) stating the number of Registrable Securities to be included and the intended method of
disposition.

After a Request has been given for a Demand Registration or a Shelf Demand another Request cannot
be given until the date that is sixty (60) days following the date of withdrawal or the effective
date of the Registration Statement relating to such previous Demand Registration or Shelf Demand.

               (d) Participations in Demand Rights. Within five (5) days following receipt of any
Request, the Company shall deliver written notice of such request (a “Demand Participation
Notice”) to all Holders of Registrable Securities other than the Initiating Holders.
Thereafter, the Company shall include in such Demand Registration any additional Registrable
Securities which the Holder or Holders thereof have, within fifteen (15) days after the Demand
Participation Notice has been given, requested in writing be included in such Demand Registration.
All such requests shall specify the aggregate amount of Registrable Securities to be registered.

               (e) Demand Withdrawal. A Holder may withdraw its Registrable Securities from a Demand
Registration at any time prior to the effective time of the Registration Statement covering the
applicable Demand Registration by giving written notice of such withdraw prior to the effective
time of such Registration Statement. If all Holders withdraw their Registrable Securities from a
Demand Registration, the Company shall cease all efforts to secure registration. The Company shall
not withdraw a Registration Statement relating to a Demand Registration without the written consent
of the Initiating Holders, unless required to do so by law, regulation or upon the request of the
SEC.

               (f) Effective Registration. The Company shall be deemed to have effected a Demand
Registration if the applicable Registration Statement is declared effective by the SEC and remains
effective as follows:

                         (1) if it is a Shelf Registration that is not a Shelf Underwritten Offering, it must remain
effective for the Shelf Period;

-8-

 

                         (2) if it is a Shelf Registration that is a Shelf Underwritten Offering, it must remain
effective for the Underwritten Period;

                         (3) if it is not a Shelf Registration and such Registration Statement does not contemplate an
Underwritten Offering, it must remain effective for the Non-Underwritten Period; or

                         (4) if it is not a Shelf Registration and such Registration Statement contemplates an
Underwritten Offering, it must remain effective for the Underwritten Period.

Notwithstanding the foregoing, no Demand Registration (including any Shelf Demand) shall be deemed
to have been effected if an Underwritten Offering is contemplated by such Demand Registration and
the conditions to closing specified in the applicable underwriting agreement are not satisfied.
Subject to Section 2.1(g), the Company shall not be deemed to have effected a Registration
Statement, or to have used its best efforts to keep the Registration Statement effective, if the
Company voluntarily takes any action or omits to take any action that would result in the inability
of any Holder of Registrable Securities covered by such Registration Statement to be able to offer
and sell any such Registrable Securities during the applicable Registration Period, unless such
action or omission is required by applicable law.

               (g) Delay or Suspension of Registration. If the filing, initial effectiveness or
continued use of a Registration Statement, including a Shelf Registration Statement, in respect of
a Demand Registration at any time would require the Company to make an Adverse Disclosure, then the
Company may, upon giving prompt written notice of such action to the Holders which are included in
such Demand Registration, delay the filing or initial effectiveness of, or suspend use of, such
Registration Statement; provided, that the Company shall not be permitted to do so in the aggregate
pursuant to this Section 2.1(g) and Section 2.2(c), (i) more than two (2) times during any twelve
(12) month period, (ii) for a period exceeding sixty (60) days on any one occasion or (iii) for a
period exceeding one hundred twenty (120) days in any twelve (12) month period. In the event the
Company exercises its rights under the preceding sentence, the Holders agree to suspend, promptly
upon their receipt of the notice referred to above, their use of the Prospectus relating to the
Demand Registration in connection with any sale or offer to sell Registrable Securities. The
Company shall promptly notify the Holders of the expiration of any period during which it exercised
its rights under this Section 2.1(g). The Company agrees that, in the event it exercises its
rights under this Section 2.1(g), it shall, as promptly as reasonably practicable following the
completion or abandonment of the transaction giving rise to the Corporation’s suspension notice,
and in any event within the time requirements set forth in this Section 2.1(g), file an amendment
to, or a Prospectus supplement with respect to, and otherwise use its best efforts to, update, the
suspended Registration Statement as may be necessary to permit the Holders to resume use thereof in
connection with the offer and sale of their Registrable Securities in accordance with applicable
law. The Company shall not be obligated to effect, or to take any action to effect, any
registration pursuant to this Section 2.1 (i) during the period that is sixty (60) days before the
Company’s good faith estimate of the date of filing of, and ending on a date that is one hundred
twenty (120) days after the effective date of, a Company-initiated registration, provided,
that the Company is actively employing in good faith commercially reasonable efforts to cause such
Registration Statement to become effective.

               (h) Underwritten Offerings.

                         (1) Demand Registrations. Any offering pursuant to a Demand Registration, other than
a Shelf Demand, shall be in the form of an Underwritten Offering upon the request of the Holders of
not less than a majority of the Registrable Securities included in any offering pursuant to a
Demand Registration.

-9-

 

                         (2) Shelf Registrations. At any time that a Shelf Registration Statement is
effective, if any Holder or group of Holders delivers a notice to the Company (an “Underwriting
Notice”) stating that it intends to effect a Shelf Underwritten Offering of all or part of its
Registrable Securities included by it on the Shelf Registration Statement and stating the Aggregate
Offering Price and/or number of the Registrable Securities to be included in the Shelf Underwritten
Offering, then the Company shall amend or supplement the Shelf Registration Statement as may be
necessary in order to enable such Registrable Securities to be distributed pursuant to the Shelf
Underwritten Offering (taking into account the inclusion of Registrable Securities by any other
Holders pursuant to this Section 2.1(h)(2)); provided, that any Shelf Underwritten Offering must
include Registrable Securities in an amount not less than the Minimum Demand Amount. In connection
with any Shelf Underwritten Offering:

                                   (A) such proposing Holder(s) shall also deliver the Underwriting Notice to all other Holders
and permit each Holder to include its Registrable Securities included on the Shelf Registration
Statement in the Shelf Underwritten Offering if such Holder notifies the proposing Holders and the
Company within 5 Business Days after delivery of the Underwriting Notice to such Holder;

                                   (B) in the event that an Underwriter Cutback Condition occurs with respect to the Registrable
Securities proposed to be included in the Shelf Underwritten Offering, then (1) the number of
Registrable Securities which will be included in the Shelf Underwritten Offering shall only be that
number which, in the good faith opinion of the underwriter, can be included without being likely to
have a significant adverse effect on the price, timing or distribution of the class of securities
offered or the market for the class of securities offered or the Common Stock, and (2) each Holder
shall be entitled to include Registrable Securities in the Shelf Underwritten Offering pro rata
based on the number of Registrable Securities owned by such Holder as a percentage of the number of
Registrable Securities owned by all Holders seeking to participate in such Shelf Underwritten
Offering, subject to the priority allocation provisions set forth in Section 2.1(h)(5); and

                                   (C) the Underwriting Notice shall state that Holders must respond to the Underwriting Notice
within five (5) Business Days of the delivery thereof.

                         (3) Selection of Underwriters. In the event that a Demand Registration is an
Underwritten Offering (including a Shelf Underwritten Offering), the Initiating Holders in such
Underwritten Offering shall have the right to select the managing underwriter or underwriters for
the offering, which underwriters must be (x) nationally recognized investment banking firm(s), and
(y) reasonably acceptable to the Company.

                         (4) Similar Securities. Without the prior written consent of the Initiating Holders
and the managing underwriter or managing underwriters of any Underwritten Offering, the Company
shall not include any securities in such Underwritten Offering unless such securities are Similar
Securities.

                         (5) Priority of Securities Registered Pursuant to Demand Registrations. If the
managing underwriter of a proposed Underwritten Offering (other than a Shelf Underwritten Offering,
which shall be governed by Section 2.1(h)(2)(B)) of Registrable Securities included in a Demand
Registration informs the Holders of such Registrable Securities in writing (a “Cutback
Notice”) that, in its or their opinion, the number of securities requested to be included in
such Demand Registration exceeds the number which can be sold in such offering without being likely
to have a significant adverse effect on the price, timing or distribution of the class of
securities offered or the market for the class of securities offered or the Common Stock, then the
Company shall include in such

-10-

 

registration only the number of Registrable Securities which, in the good faith opinion of
such underwriter, can be included without having such an adverse effect, selected in the following
order:

                                   (A) first, the Registrable Securities requested to be included by the Initiating
Holders and the Holders who are Participating Holders with respect thereto, allocated pro rata
based on the number of Registrable Securities owned by such Holder as a percentage of the number of
Registrable Securities owned by all Holders seeking to participate in such Underwritten Offering;
and

                                   (B) second, Similar Securities, if any, requested to be included by the Company or by
other Holders, allocated among them as they shall so determine;

provided, however, in no event shall any particular Holder be permitted to include in such
registration any Registrable Securities in excess of the number of Registrable Securities which
such Holder originally sought to include in such registration. In the event of a cutback pursuant
to this Section 2.1(h), each of the Holders agrees that it will not include Registrable Securities
in any registration effected pursuant to the Securities Act in a manner that is not in compliance
with the foregoing priorities.

               (i) Registration Statement Form. Demand Registrations shall be on such appropriate
registration form of the SEC (A) as shall be selected by the Initiating Holders of the Demand
Registration and as shall be reasonably acceptable to the Company, and (B) as shall facilitate and
permit the disposition of the Registrable Securities in accordance with the intended method or
methods of disposition specified in the applicable Holders’ requests for such registration.
Notwithstanding the foregoing, if, pursuant to a Demand Registration, (x) the registration is
proposed to be effected by filing a Registration Statement on Form S-3 (or any successor form under
the Securities Act), (y) such registration is in connection with an Underwritten Offering and (z)
the managing underwriter or underwriters advises the Company that, in its or their opinion, the
inclusion, rather than the incorporation by reference, of information in the Prospectus is of
material importance to the success of such proposed offering, then such information shall be so
included in such Prospectus.

          Section 2.2 Incidental Registrations.

               (a) Participation.

                         (1) At any time, or from time to time, after the Company has become subject to the periodic
reporting requirements of the Exchange Act or otherwise lists shares of its Common Stock on a
recognized securities exchange, Nasdaq or another trading medium, if the Company at any time files
a Registration Statement (other than a Registration Statement filed pursuant to Rule 462(b) under
the Securities Act) with respect to any offering of its securities for its own account or for the
account of any stockholder who holds its securities (other than (A) a registration on Form S-4,
F-4, F-8, F-10 or S-8 or any successor form to such forms, (B) a registration of securities solely
relating to an offering and sale to employees, directors or consultants of the Company pursuant to
any employee stock plan or other employee benefit plan arrangement or (C) a registration of
non-convertible debt securities) then, as expeditiously as reasonably possible, the Company shall
give written notice (the “Incidental Registration Notice”) of such filing to all Holders of
Registrable Securities, and such notice shall offer the Holders of such Registrable Securities the
opportunity to register such number of Registrable Securities as each such Holder may request in
writing. Subject to Section 2.2(b), the Company shall include in such Registration Statement all
such Registrable Securities which are requested to be included therein within fifteen (15) days
after the Incidental Registration Notice is given to such Holders. If at any time after giving
written notice of its intention to register any securities and prior to the effective date of the
Registration Statement filed in connection with such registration, the Company shall determine for
any

-11-

 

reason not to register or to delay registration of such securities, the Company may, at its
election, give written notice of such determination to each Holder of Registrable Securities and,

                                   (A) in the case of a determination not to register, shall be relieved of its obligation to
register any Registrable Securities in connection with such registration, and

                                   (B) in the case of a determination to delay registering, shall be permitted to delay
registering any Registrable Securities for the same period as the delay in registering such other
securities.

                         (2) If the offering described in an Incidental Registration Notice is to be an Underwritten
Offering, then each Holder making a request for its Registrable Securities to be included therein
must, and the Company shall make such arrangements with the underwriters so that each such Holder
may, participate in such Underwritten Offering on the same terms as the Company and other Persons
selling securities in such Underwritten Offering, subject to the provisions of Section 2.4. If the
offering pursuant to such registration is to be on any other basis, then each Holder making a
request for an Incidental Registration pursuant to this Section 2.2(a) must participate in such
offering on such basis.

                         (3) Each Holder of Registrable Securities making a request for an Incidental Registration
pursuant to this Section 2.2(a) shall be permitted to withdraw all or part of such Holder’s
Registrable Securities from such Incidental Registration at any time prior to the effective time of
the Registration Statement covering the applicable Incidental Registration by giving written notice
of such withdraw prior to the effective time of such Registration Statement.

               (b) Priority of Incidental Registration. If the managing underwriter or underwriters
of any proposed Underwritten Offering of securities included in an Incidental Registration informs
the Holders of Registrable Securities sought to be included in such registration pursuant to
Section 2.2(a) in writing (an “Incidental Cutback Notice”) that, in its or their opinion,
the total amount or kind of securities which such Holders and any other Persons intend to include
in such offering exceeds the number which can be sold in such offering without being likely to have
a significant adverse effect on the price, timing or distribution of the class of the securities
offered or the market for the class of securities offered or for the Common Stock (the foregoing,
an “Underwriter Cutback Condition”), then the Company shall include in such registration
only the number of Registrable Securities which, in the good faith opinion of such underwriter can
be included without having such an adverse effect, selected in the following order:

                         (1) if the registration is being effected by stockholders of the Company pursuant to the
exercise of contractual demand registration rights (other than pursuant to the exercise of Demand
Rights under this Agreement, in which event the provisions of Section 2.1(h)(5) shall govern),

                                   (A) first, the securities, if any, being sold by such other stockholders exercising
such demand registration rights, allocated as they and the Company shall so determine;

                                   (B) second, the Registrable Securities, if any, requested to be included by the
Holders pursuant to this Section 2.2 allocated pro rata based on the number of Registrable
Securities owned by such Holder as a percentage of the number of Registrable Securities held by all
Holders seeking to participate in such registration; and

-12-

 

                                   (C) third, securities, if any, requested to be included by the Company and by any
other stockholders of the Company in accordance with agreements between the Company and such other
stockholders, allocated among them as they shall so determine;

provided, however, in no event shall any particular Holder be permitted to include in such
registration any Registrable Securities in excess of the number of Registrable Securities which
such Holder originally sought to include in such registration; and

                         (2) if the registration is being effected by the Company for its own account or is a Target
Registration,

                                   (A) first, the securities, if any, being sold by the Company and the Holders of the
Company’s securities for whom the Target Registration is undertaken, allocated among them as they
shall so determine;

                                   (B) second, the Registrable Securities, if any, requested to be included by the
Holders pursuant to Section 2.2, allocated pro rata based on the on the number of Registrable
Securities owned by such Holder as a percentage of the number of Registrable Securities held by all
Holders seeking to participate in such registration; and

                                   (C) third, the securities, if any, requested to be included by any other stockholders
of the Company in accordance with agreements between the Company and such other, allocated in
accordance with such agreements;

provided, however, in no event shall any particular Holder be permitted to include in such
registration any Registrable Securities in excess of the number of Registrable Securities which
such Holder originally sought to include in such registration. In the event of a cutback pursuant
to this Section 2.2(b), each of the Holders agrees that it will not include Registrable Securities
in any registration effected pursuant to the Securities Act in a manner that is not in compliance
with the foregoing priorities set forth in Section 2.2(b)(1) and Section 2.2(b)(2).

               (c) Suspension or Termination of Registration. If the filing, initial effectiveness
or continued use of a Registration Statement, including a Shelf Registration Statement, in respect
of an Incidental Registration at any time would require the Company to make an Adverse Disclosure,
then the Company may, upon giving prompt written notice of such action to the Holders which are
included in such Incidental Registration, delay the filing or initial effectiveness of, or suspend
use of, such Registration Statement; provided, that the Company shall not be permitted to do so in
the aggregate pursuant to this Section 2.2(c) and Section 2.1(g), (i) more than two (2) times
during any twelve (12) month period, (ii) for a period exceeding 60 days on any one occasion or
(iii) for a period exceeding one hundred twenty (120) days in any twelve (12) month period. In the
event the Company exercises its rights under the preceding sentence, promptly upon their receipt of
the notice referred to above the Holders agree to suspend, and in the case of an Underwritten
Offering (including a Shelf Underwritten Offering), the Company and the Holders agree to cause any
underwriter to suspend, their use of the Prospectus relating to the Incidental Registration in
connection with any sale or offer to sell Registrable Securities. The Company shall promptly
notify the Holders of the expiration of any period during which it exercised its rights under this
Section 2.2(c). The Company agrees that, in the event it exercises its rights under this Section
2.2(c), it shall, as promptly as reasonably practicable following the completion or abandonment of
the transaction giving rise to the Corporation’s suspension notice, and in any event within the
time requirements set forth in this Section 2.2(c), file an amendment to, or a Prospectus
supplement with respect to, and otherwise use its best efforts to, update, the suspended
Registration Statement as may be necessary to permit the Holders to resume use thereof in
connection with the offer

-13-

 

and sale of their Registrable Securities in accordance with applicable law. Notwithstanding
any other provision of this (c), the Company shall have the right to terminate or withdraw any
registration initiated by it under this (c) before the effective date of such registration, whether
or not any Holder has elected to include Registrable Securities in such registration.

          Section 2.3 Registration Procedures.

               (a) In connection with the Company’s registration obligations in this Agreement, the Company
will, subject to the limitations set forth herein, use its best efforts to effect any such
registration so as to permit the sale of the applicable Registrable Securities in accordance with
the intended method or methods of distribution thereof as expeditiously as reasonably possible and,
in connection therewith, the Company will:

                         (1) before filing a Registration Statement or Prospectus, or any amendments or supplements
thereto and in connection therewith, furnish to the managing underwriter or underwriters, if any,
and to one representative of each Holder (and its Affiliates) which has requested that Registrable
Securities be covered by such Registration Statement, copies of all documents prepared to be filed,
which documents will be subject to the review of such underwriters and such Holders and their
respective counsel and not file any Registration Statement or Prospectus or amendments or
supplements thereto to which the Holders of a majority of the Registrable Securities covered by the
same or the underwriter or underwriters, if any, shall reasonably object;

                         (2) prepare and file with the SEC such amendments or supplements to the applicable
Registration Statement or Prospectus as may be (A) reasonably requested by any selling Holder (to
the extent such request relates to information relating to such Holder), or (B) necessary to keep
such registration effective for the period of time required by this Agreement;

                         (3) notify the selling Holders of Registrable Securities and the managing underwriter or
underwriters, if any, and (if requested) confirm such advice in writing, as expeditiously as
reasonably possible after notice thereof is received by the Company (A) when the applicable
Registration Statement or any amendment thereto has been filed or becomes effective and when the
applicable Prospectus or any amendment or supplement thereto has been filed, (B) of any written or
material oral comments by the SEC or any request by the SEC or any other federal or state
governmental authority for amendments or supplements to such Registration Statement or Prospectus
or for additional information, (C) of the issuance by the SEC of any stop order suspending the
effectiveness of such Registration Statement or any order preventing or suspending the use of any
preliminary or final Prospectus or the initiation or threat of any proceedings for such purposes
and (D) of the receipt by the Company of any notification with respect to the suspension of the
qualification of the Registrable Securities for offering or sale in any jurisdiction or the
initiation or threat of any proceeding for such purpose;

                         (4) promptly notify each selling Holder of Registrable Securities and the managing underwriter
or underwriters, if any, when the Company becomes aware of the happening of any event as a result
of which the applicable Registration Statement or Prospectus (as then in effect) contains any
untrue statement of a material fact or omits to state a material fact necessary to make the
statements therein (in the case of the Prospectus and any preliminary Prospectus, in light of the
circumstances under which they were made) not misleading or, if for any other reason it shall be
necessary to amend or supplement such Registration Statement or Prospectus in order to comply with
the Securities Act and, in either case as promptly as reasonably practicable thereafter (except as
otherwise provided under Section 2.1(g) or Section 2.2(c)), prepare and file with the SEC an
amendment or

-14-

 

supplement to such Registration Statement or Prospectus which will correct such statement or
omission or effect such compliance;

                         (5) use its best efforts to prevent or obtain at the earliest possible moment the withdrawal
of any stop order with respect to the applicable Registration Statement or other order suspending
the use of any preliminary or final Prospectus;

                         (6) promptly incorporate in a Prospectus supplement or post-effective amendment to the
applicable Registration Statement such information as the managing underwriter or underwriters, if
any, or the Initiating Holders agree should be included therein relating to the plan of
distribution with respect to such Registrable Securities; and make all required filings of such
Prospectus supplement or post-effective amendment as expeditiously as reasonably possible after
being notified of the matters to be incorporated in such Prospectus supplement or post-effective
amendment;

                         (7) furnish to each selling Holder of Registrable Securities, its counsel and each managing
underwriter, if any, without charge, as many conformed copies as such Holder or managing
underwriter may reasonably request of the applicable Registration Statement and each amendment
thereto;

                         (8) deliver to each selling Holder of Registrable Securities and each managing underwriter, if
any, without charge, as many copies of the applicable Prospectus (including each preliminary
Prospectus) as such Holder or managing underwriter may reasonably request, and such other documents
as such selling Holder or managing underwriter may reasonably request in order to facilitate the
disposition of the Registrable Securities by such Holder or underwriter;

                         (9) on or prior to the date on which the applicable Registration Statement is declared
effective, use its best efforts to register or qualify such Registrable Securities for offer and
sale under the securities or “blue sky” laws of each state and other jurisdiction of the United
States, as any such selling Holder or underwriter, if any, or their respective counsel reasonably
requests in writing, and do any and all other acts or things reasonably necessary or advisable to
keep such registration or qualification in effect so as to permit the commencement and continuance
of sales and dealings in such jurisdictions for as long as may be necessary to complete the
distribution of the Registrable Securities covered by the Registration Statement; provided, that
the Company will not be required to qualify generally to do business in any jurisdiction where it
is not then so qualified or to take any action which would subject it to taxation or general
service of process in any such jurisdiction where it is not then so subject;

                         (10) cooperate with the selling Holders of Registrable Securities and the managing
underwriter, underwriters or agent, if any, to facilitate the timely preparation and delivery of
certificates representing Registrable Securities to be sold and not bearing any restrictive
legends;

                         (11) use its best efforts to cause the Registrable Securities covered by the applicable
Registration Statement to be registered with or approved by such other governmental agencies or
authorities as may be necessary to enable the seller or sellers thereof or the underwriter or
underwriters, if any, to consummate the disposition of such Registrable Securities;

                         (12) not later than the effective date of the applicable Registration Statement, provide a
CUSIP number for all Registrable Securities and provide the applicable transfer agent with printed
certificates for the Registrable Securities which certificates shall be in a form eligible for
deposit with The Depository Trust Company;

-15-

 

                         (13) obtain for delivery to (and addressed to) the underwriter or underwriters, an opinion or
opinions from counsel for the Company dated the date of the closing under the underwriting
agreement, in customary form, scope and substance, which counsel and opinions shall be reasonably
satisfactory to a majority of such Holders and the managing underwriter or underwriters, if any,
and their respective counsel;

                         (14) in the case of an Underwritten Offering (including a Shelf Underwritten Offering), obtain
for delivery to (and addressed to) the Company and the underwriter or underwriters, a cold comfort
letter from the Company’s independent certified public accountants in customary form and covering
such matters of the type customarily covered by cold comfort letters as the managing underwriter or
underwriters reasonably request, dated the date of execution of the underwriting agreement and
brought down to the closing under the underwriting agreement;

                         (15) cooperate with each selling holder of Registrable Securities and each underwriter or
agent, if any, participating in the disposition of such Registrable Securities and their respective
counsel in connection with any filings required to be made with the NASD;

                         (16) use its best efforts to comply with all applicable rules and regulations of the SEC and
make generally available to its security holders, as expeditiously as reasonably possible after the
effective date of the applicable Registration Statement, but not later than sixty (60) days after
the date of the most recent fiscal quarter, an earnings statement satisfying the provisions of
Section 11(a) of the Securities Act and the rules and regulations promulgated thereunder;

                         (17) provide and cause to be maintained a transfer agent and registrar for all Registrable
Securities covered by the applicable Registration Statement from and after a date not later than
the effective date of such Registration Statement;

                         (18) cause all Registrable Securities of a class covered by the applicable Registration
Statement to be listed on each securities exchange and inter-dealer quotation system on which any
of the Company’s securities of such class are then listed or quoted;

                         (19) make available upon reasonable notice at reasonable times and for reasonable periods for
inspection by representatives appointed by the Holders of a majority of the Registrable Securities
covered by the applicable Registration Statement, by any managing underwriter or underwriters
participating in any disposition to be effected pursuant to such Registration Statement, and by any
attorney, accountant or other agent retained by such sellers or any such managing underwriter, all
pertinent financial and other records, pertinent corporate documents and properties of the Company,
and cause the Company’s senior executive officers, directors and employees and the independent
public accountants who have certified its financial statements to make themselves available at
mutually convenient times to discuss the business of the Company and to supply all information
reasonably requested by any such sellers, underwriter or agent thereof in connection with such
Registration Statement as shall be necessary (subject to the Company’s compliance with Regulation
FD) to enable them to exercise their due diligence responsibility;

                         (20) in the case of an Underwritten Offering (including any Shelf Underwritten Offering),
cause the senior executive officers of the Company to participate in the customary “road show”
presentations that may be reasonably requested by the managing underwriter in any such Underwritten
Offering and otherwise to facilitate, cooperate with, and participate in each proposed offering
contemplated herein and customary selling efforts related thereto;

                         (21) upon the request of any Holder, promptly amend any Shelf Registration Statement or take
such other action as may be necessary to de-register, remove or withdraw

-16-

 

all or a portion of the Holder’s Registrable Shares from a Shelf Registration Statement, as
requested by such Holder; and

                         (22) use its best efforts to take all other steps necessary to effect the registration of the
Registrable Securities contemplated hereby.

               (b) It shall be a condition precedent to the obligations of the Company to take any action
pursuant to this Article 2 with respect to the Registrable Securities of any selling Holder that
each selling Holder of Registrable Securities as to which any registration is being effected shall
furnish to the Company such information regarding the distribution of such Registrable Securities
and such other customary information relating to such Holder and its ownership of the applicable
Registrable Securities as the Company may from time to time reasonably request and as shall be
reasonably required in connection with any Registration Statement. Each Holder of Registrable
Securities agrees to furnish such information to the Company and to reasonably cooperate with the
Company as necessary to enable the Company to comply with the provisions of this Agreement.

               (c) Each Holder of Registrable Securities agrees by acquisition of such Registrable Securities
that, upon receipt of any notice from the Company of the happening of any event of the kind
described in Section 2.3(a)(4), such Holder will use its best efforts to discontinue disposition of
its Registrable Securities pursuant to such Registration Statement until such Holder’s receipt of
the copies of the supplemented or amended Prospectus contemplated by Section 2.3(a)(4), or until
such Holder is advised by the Company that the use of the Prospectus may be resumed, and has
received copies of any additional or supplemental filings that are incorporated by reference in the
Prospectus. In the event that the Company shall give any such notice in respect of a Demand
Registration, the period during which the applicable Registration Statement is required to be
maintained effective shall be extended by the number of days during the period from and including
the date of the giving of such notice to and including the date when each seller of Registrable
Securities covered by such Registration Statement either receives the copies of the supplemented or
amended Prospectus contemplated by Section 2.3(a)(4) or is advised in writing by the Company that
the use of the Prospectus may be resumed.

          Section 2.4 Underwritten Offerings.

               (a) Underwriting Agreements. If requested by the managing underwriter or underwriters
for any Demand Registration that is an Underwritten Offering (including a Shelf Underwritten
Offering), the Company and the Holders of Registrable Securities to be included therein shall enter
into an underwriting agreement with such underwriters, to contain such terms and conditions as are
generally prevailing in agreements of that type, including indemnities no more burdensome to the
indemnifying party and no less favorable to the recipient thereof than those provided in Section
2.7. The Holders of any Registrable Securities to be included pursuant to Section 2.2(a) in any
Incidental Registration that is an Underwritten Offering (excluding any Demand Registration or
Shelf Underwritten Offering) shall enter into such an underwriting agreement at the request of the
Company. No Holder shall be required in any such underwriting agreement to make any
representations or warranties to or agreements with the Company or the underwriters other than
customary representations, warranties or agreements regarding such Holders’ title to Registrable
Securities and any written information provided by the Holder to the Company expressly for
inclusion in the related registration statement.

               (b) Price and Underwriting Discounts. In the case of a Demand Registration that is an
Underwritten Offering (including a Shelf Underwritten Offering), the price, underwriting discount
and other financial terms for the sale of the Registrable Securities shall be determined by the
Initiating Holders of such Demand Registration. In the case of any Incidental Registration that is
an Underwritten Offering (excluding any Demand Registration or Shelf Underwritten Offering), such
price,

-17-

 

discount and other terms shall be determined (i) by the Company in the case of a registration
governed by Section 2.2(b)(2), or (ii) by the holders of a majority of the Registrable Securities
registered for the account of stockholders exercising demand registration rights, in the case of a
registration governed by Section 2.2(b)(1), or in accordance with an agreement among the Company
and such majority holders.

               (c) Participation in Underwritten Offerings. No Person may participate in an
Underwritten Offering (including a Shelf Underwritten Offering) unless such Person (i) agrees to
sell such Person’s securities on the basis provided in any underwriting arrangements approved by
officers of such Persons authorized to approve such arrangements, (ii) executes and delivers the
underwriting agreement and all other documents required under the terms of such underwriting
arrangements and (iii) completes, executes and delivers all questionnaires, powers of attorney,
custody agreements, indemnities and opinions reasonably requested by the Company and customary for
secondary offerings.

          Section 2.5 No Inconsistent Agreements; Additional Rights. The Company will not enter into, and is not currently a party to, any agreement which is
inconsistent with the rights granted to the Holders of Registrable Securities by this Agreement.
If the Company enters into any agreement after the date hereof granting any person registration
rights with respect to any security of the Company which agreement contains any material provisions
more favorable to such person than those set forth in this Agreement, the Company will notify the
Holders and will agree to such amendments to this Agreement as may be necessary to provide these
rights to the Holders.

          Section 2.6 Registration Expenses.

               (a) The Company shall pay all of the expenses incurred in connection with its compliance with
Article 2, including (i) all registration and filing fees, and any other fees and expenses
associated with filings required to be made with the SEC or the NASD, (ii) all fees and expenses of
compliance with state securities or “blue sky” laws, including all reasonable fees and
disbursements of one counsel in connection with any survey of state securities or “blue sky” laws
and the preparation of any memorandum thereon, (iii) all printing, duplicating, word processing,
messenger, telephone, facsimile and delivery expenses related to the preparation by the Company of
any Registration Statement or Prospectus, agreements with underwriters, and any other ancillary
agreements, certificates or documents arising out of or related to the foregoing (including
expenses of printing certificates for the Registrable Securities in a form eligible for deposit
with The Depository Trust Company and of printing prospectuses), (iv) all fees and disbursements of
counsel for the Company and of all independent certified public accountants of the Company, and (v)
all fees and expenses incurred in connection with the listing of the Registrable Securities on any
securities exchange, Nasdaq, or other trading medium. In addition, in all cases the Company shall
pay its internal expenses (including all salaries and expenses of its officers and employees
performing legal or accounting duties), the expense of any audit and the fees and expenses of any
Person, including special experts, retained by the Company. In addition, the Company shall pay all
reasonable fees and disbursements of one law firm or other counsel selected by the holders of a
majority of the Registrable Securities being registered, subject to a reasonable cap to be agreed
upon by the Issuer and the holders in light of the laws and regulations existing at the time of the
applicable Registration, and if there exists no material change in legal requirements imposed on
registering holders after the date of this Agreement, then such cap will not exceed $25,000;
provided, however, that the Company shall not be required to pay for any expenses of any
registration proceeding begun pursuant to Section 2.1 if the registration request is subsequently
withdrawn at the request of the Initiating Holders (in which case the Initiating Holders shall bear
such expenses pro rata based upon the number of Registrable Securities that were to be included in
the withdrawn registration), unless such Holders agree to forfeit their right to one registration
pursuant to Section 2.1.

-18-

 

               (b) The Company shall not be required to pay any other costs or expenses in the course of an
offering of Registrable Securities pursuant to this Agreement, including underwriting discounts and
commissions and transfer taxes attributable to the sale of Registrable Securities and the fees and
expenses of counsel to the Holders or the underwriters, other than pursuant to Section 2.6(a).

          Section 2.7 Indemnification.

               (a) Indemnification by the Company. The Company agrees to indemnify and hold
harmless, to the full extent permitted by law, each selling Holder of Registrable Securities and
their respective directors, officers and partners, and each Person who controls (within the meaning
of the Securities Act or the Exchange Act) such Persons (each, an “Indemnified Person”)
from and against any and all losses, claims, damages, liabilities (or actions or proceedings in
respect thereof, whether or not such Indemnified Person is a party thereto) and expenses (including
reasonable costs of investigation and legal expenses), joint or several (each, a “Loss” and
collectively “Losses”), arising out of or based upon (i) any misstatement in or omission
from any representation or warranty, or any breach of covenant or agreement, in each case made or
deemed made by the Company in any underwriting or similar agreement entered into by the Company in
connection with any Registration Statement, (ii) any violation by the Company of the Securities Act
or any state securities or “blue sky” laws, rules or regulations, in either case in connection with
any Registration Statement, (iii) any untrue or alleged untrue statement of a material fact
contained in any Registration Statement under which such Registrable Securities were registered
under the Securities Act (including any final, preliminary or summary Prospectus contained therein
or any amendment thereof or supplement thereto or any documents incorporated by reference therein)
or (iv) any omission or alleged omission to state therein a material fact required to be stated
therein or necessary to make the statements therein (in the case of a Prospectus or preliminary
Prospectus, in light of the circumstances under which they were made) not misleading; provided,
however, that the Company shall not be liable to indemnify an Indemnified Person to the extent that
any such Loss arises out of or is based upon an untrue statement or alleged untrue statement or
omission or alleged omission made in any such Registration Statement in reliance upon and in
conformity with written information furnished to the Company by such Holder expressly for use in
the preparation thereof or arises out of or is based upon such Holder’s failure to deliver a copy
of the Prospectus or any amendments or supplements thereto to a purchaser (if so required) after
the Company has furnished such Holder with a copy of the same. This indemnity shall be in addition
to any liability the Company may otherwise have. Such indemnity shall remain in full force and
effect regardless of any investigation made by or on behalf of such Holder or any Indemnified
Person and shall survive the transfer of such securities by such Holder. The Company will also
indemnify, if the offering is an Underwritten Offering (including a Shelf Underwritten Offering)
and if requested, underwriters participating in any distribution pursuant to this Agreement, their
officers, directors and partners, and each Person who controls such Persons (within the meaning of
the Securities Act and the Exchange Act) to the same extent as provided above (with appropriate
modifications) with respect to the indemnification of each Holder.

               (b) Indemnification by the Holders. Each selling Holder of Registrable Securities
agrees (severally and not jointly) to indemnify and hold harmless, to the full extent permitted by
law, the Company, its directors, officers and partners, and each Person who controls the Company
(within the meaning of the Securities Act and the Exchange Act), and each other selling Holder of
Registrable Securities, their respective officers, directors and partners, and each Person who
controls (within the meaning of the Securities Act or the Exchange Act) such Person, from and
against any Losses resulting from (i) any untrue or allegedly untrue statement of a material fact
or any omission or alleged omission of a material fact required to be stated in the Registration
Statement under which such Registrable Securities were registered under the Securities Act
(including any final, preliminary or summary Prospectus contained therein or any amendment thereof
or supplement thereto or any documents incorporated by reference therein), or necessary to make the
statements therein (in the case of

-19-

 

a Prospectus or preliminary Prospectus, in light of the circumstances under which they were
made) not misleading, to the extent, but only to the extent, that such untrue statement or omission
had been contained in any information furnished in writing by such selling Holder to the Company
expressly for inclusion in such Registration Statement, and (ii) any misstatement in or omission
from any representation or warranty, or any breach of covenant or agreement, in each case made or
deemed made by such Holder in any underwriting or similar agreement entered by into by such Holder
in connection with the particular registration. Each Holder also shall indemnify any underwriters
of the Registrable Securities, their officers, directors and partners, and each Person who controls
such underwriters (within the meaning of the Securities Act) to the same extent as provided above
with respect to the indemnification of the Company. The liability of any Holder for
indemnification under this Section 2.7 in its capacity as a seller of Registrable Securities shall
not exceed the lesser of (i) that proportion of the total of such losses, claims, damages, expenses
or liabilities indemnified against equal to the proportion of the total securities sold under such
registration statement held by such Investor, and (ii) the amount equal to the net proceeds to
such Holder of the securities sold in any such registration; provided that no selling holder shall
be required to indemnify any Person against any Losses arising from any untrue statement or alleged
untrue statement of a material fact contained in, or omission or alleged omission of a material
fact from, a preliminary Prospectus (or necessary to make the statements therein not misleading)
that has been corrected in the form of Prospectus included in the Registration Statement at the
time it becomes effective, or any amendment or supplement thereto filed with the SEC pursuant to
Rule 424(b) under the Securities Act prior to the time of sale of Registrable Securities that gives
rise to such Losses.

               (c) Indemnification by Securities Industry Professionals. The Company shall use
commercially reasonable efforts to obtain the agreement of the underwriters, if any, participating
in a particular Underwritten Offering (including a Shelf Underwritten Offering), to provide
indemnities for the benefit of the Company and the Holders of Registrable Securities participating
in the distribution, to the same extent as provided in Section 2.7(b) (with appropriate
modification) with respect to information so furnished in writing by such underwriters specifically
for inclusion in any Prospectus or Registration Statement.

               (d) Conduct of Indemnification Proceedings. Any Person entitled to indemnification
hereunder will (i) give prompt written notice to the indemnifying party of any claim with respect
to which it seeks indemnification (provided, that any delay or failure to so notify the
indemnifying party shall relieve the indemnifying party of its obligations hereunder only to the
extent, if at all, that it is actually and materially prejudiced by reason of such delay or
failure) and (ii) permit such indemnifying party to assume the defense of such claim with counsel
reasonably satisfactory to the Indemnified Person; provided, that any Person entitled to
indemnification hereunder shall have the right to select and employ separate counsel and to
participate in the defense of such claim, but the fees and expenses of such counsel shall be at the
expense of such Person unless (A) the indemnifying party has agreed in writing to pay such fees or
expenses, (B) the indemnifying party shall have failed to assume the defense of such claim within a
reasonable time after having received notice of such claim from the Person entitled to
indemnification hereunder and to employ counsel reasonably satisfactory to such Person, (C) in the
reasonable judgment of any such Person, based upon advice of its counsel, a conflict of interest
exists or may potentially exist between such Person and the indemnifying party with respect to such
claims or (D) the Indemnified Person has reasonably concluded (based on advice of counsel) that
there may be legal defenses available to it or other indemnified parties that are different from or
in addition to those available to the indemnifying party (in the case of (B), (C) and (D), if the
Person notifies the indemnifying party in writing that such Person elects to employ separate
counsel at the expense of the indemnifying party, the indemnifying party shall not have the right
to assume the defense of such claim on behalf of such Person). If such defense is not assumed by
the indemnifying party, the indemnifying party will not be subject to any liability for any
settlement made without its consent, but such consent may not be unreasonably withheld; provided,
that an indemnifying party may withhold its consent to any settlement involving the

-20-

 

imposition of equitable remedies or involving the imposition of any material obligations on
such indemnifying party other than financial obligations for which such Indemnified Person will be
indemnified hereunder. No indemnifying party shall consent to entry of any judgment or enter into
any settlement which does not include as an unconditional term thereof the giving by the claimant
or plaintiff to each Indemnified Person of an unconditional release from all liability in respect
to such claim or litigation. The indemnifying party or parties shall not, in connection with any
proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees,
disbursements and other charges of more than one separate firm (together with one firm of local
counsel) at any one time for all Indemnified Parties unless (x) the employment of more than one
counsel has been authorized in writing by the indemnifying party or parties, (y) a conflict or
potential conflict exists or may exist (based on advice of counsel to an Indemnified Person)
between such Indemnified Person and the other Indemnified Parties or (z) an Indemnified Person has
reasonably concluded (based on advice of counsel) that there may be legal defenses available to it
that are different from or in addition to those available to the other Indemnified Parties, in each
of which cases the indemnifying party shall be obligated to pay the reasonable fees and expenses of
such additional counsel or counsels.

               (e) Contribution. If for any reason the indemnification provided for in Section
2.7(a) and Section 2.7(b) is unavailable to an Indemnified Person or insufficient to hold it
harmless as contemplated by Section 2.7(a) and Section 2.7(b), then the indemnifying party shall
contribute to the amount paid or payable by the Indemnified Person as a result of such Loss in such
proportion as is appropriate to reflect the relative fault of the indemnifying party on the one
hand and the Indemnified Person on the other. The relative fault shall be determined by reference
to, among other things, whether the untrue or alleged untrue statement of a material fact or the
omission or alleged omission to state a material fact relates to information supplied by the
indemnifying party or the Indemnified Person and the parties’ relative intent, knowledge, access to
information and opportunity to correct or prevent such untrue statement or omission.
Notwithstanding anything in this Section 2.7(e) to the contrary, no indemnifying party (other than
the Company) shall be required pursuant to this Section 2.7(e) to contribute any amount in excess
of the amount by which the net proceeds received by such indemnifying party from the sale of
Registrable Securities in the offering to which the Losses of the Indemnified Parties relate
exceeds the amount of any damages which such indemnifying party has otherwise been required to pay
by reason of such untrue statement or omission. The parties to this Agreement agree that it would
not be just and equitable if contribution pursuant to this Section 2.7(e) were determined by pro
rata allocation or by any other method of allocation that does not take account of the equitable
considerations referred to in this Section 2.7(e). No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any Person who was not guilty of such fraudulent misrepresentation.

          Section 2.8 Rules 144 and 144A. The Company covenants that, from and after the time it becomes subject to the periodic
reporting requirements of the Exchange Act, it will file the reports required to be filed by it
under the Securities Act and the Exchange Act and the rules and regulations adopted by the SEC
thereunder (or, if the Company thereafter is no longer required to file such reports, it will, upon
the request of any Holder of Registrable Securities, make publicly available other information so
long as necessary to permit sales pursuant to Rule 144 and 144A under the Securities Act), and it
will take such further action as any Holder of Registrable Securities may reasonably request, all
to the extent required from time to time to enable such Holder to sell Registrable Securities
without registration under the Securities Act within the limitation of the exemptions provided by
(i) Rule 144 or 144A or Regulation S under the Securities Act, as such Rules may be amended from
time to time, or (ii) any similar rule or regulation hereafter adopted by the SEC. Upon the request
of any Holder of Registrable Securities, the Company will deliver to such Holder a written
statement as to whether it has complied with such requirements and, if not, the specifics thereof.

-21-

 

          Section 2.9 Holdback. The parties acknowledge that they are parties to the Stockholders Agreement which contains
restrictions on the sale of securities during specified periods of time in connection with the
Company’s filing of a Registration Statement.

          Section 2.10 Canadian Registration. If, after the 180th day following the date of the final prospectus relating to the
initial public offering of the Company’s Common Stock, the Company files a prospectus with any
Canadian provincial securities commission from time to time, the Company will use its best efforts
to facilitate and enable the Holders to make a secondary offering of Registrable Securities in
Canada to the fullest extent permitted by applicable securities laws, subject to the approval by
the underwriters or agents involved in the offering and the applicable securities regulators.

ARTICLE 3

MISCELLANEOUS

          Section 3.1 Injunctive Relief. It is hereby agreed and acknowledged that it will be impossible to measure in money the
damages that would be suffered if the parties fail to comply with any of the obligations herein
imposed on them and that in the event of any such failure, an aggrieved Person will be irreparably
damaged and will not have an adequate remedy at law. Any such Person shall, therefore, be entitled
(in addition to any other remedy to which it may be entitled in law or in equity) to injunctive
relief, including specific performance, to enforce such obligations, without the requirement that a
bond be posted and, if any action should be brought in equity to enforce any of the provisions of
this Agreement, none of the parties to this Agreement shall raise the defense that there is an
adequate remedy at law. Notwithstanding the foregoing, no Holder shall have any right to obtain or
seek an injunction restraining or otherwise delaying any registration pursuant to this Agreement as
the result of any controversy that might arise with respect to the interpretation or implementation
of Section 2 hereof.

          Section 3.2 Notices. All notices or other communications which are required or permitted hereunder shall be in
writing and sufficient if delivered by hand, by facsimile transmission, by registered or certified
mail, postage pre-paid, or by courier or overnight carrier, to the Persons at the addresses set
forth in Schedule A and Schedule B in the case of a Holder and to the address set
forth below in the case of the Company (or at such other address as may be provided hereunder), and
shall be deemed to have been delivered (a) on the date of delivery if delivered personally, or by
telecopy or facsimile, upon confirmation of receipt, (b) on the first Business Day following the
date of dispatch if delivered by a recognized next-day courier service, or (c) on the fifth
Business Day following the date of mailing if delivered by registered or certified mail return
receipt requested, postage prepaid:

if to the Company to:

Lululemon Corp.

2285 Clark Drive

Vancouver, BC Canada

V5N 3G9

Facsimile:

Attention: Chief Executive Officer

-22-

 

with copies to:

Advent International Corporation

75 State Street

Boston, MA 02109

Facsimile: (617) 951-0568

Attention: Steven J. Collins

and

Pepper Hamilton LLP

3000 Two Logan Square

Eighteenth & Arch Streets

Philadelphia, PA 19103

Facsimile: (215) 981-4750

Attention: Robert A. Friedel

          Section 3.3 Successors, Assigns and Transferees.

               (a) The registration rights of any Holder under this Agreement with respect to any Registrable
Securities may be transferred and assigned; provided, that no such assignment shall be binding upon
or obligate the Company to any such transferee or assignee unless and until the Company shall have
received notice of such assignment as herein provided and a written agreement of the assignee to be
bound by the provisions of this Agreement by executing a Counterpart Signature Page; and provided
further that the registration rights of any Holder under this Agreement may not be transferred or
assigned to any employee or former employee of the Company or any of its subsidiaries. Any
transfer or assignment made other than as provided in the first sentence of this Section 3.3(a)
shall be null and void.

               (b) Schedule A and Schedule B shall be deemed to be amended to add any party
delivering a Counterpart Signature Page pursuant to this Section 3.3(a).

               (c) This Agreement shall be binding upon and shall inure to the benefit of the parties to this
Agreement, and their respective successors and permitted assigns.

          Section 3.4 Choice of Law; Jurisdiction; Venue; WAIVER OF JURY TRIAL.

               (a) This Agreement shall be construed and enforced in accordance with the laws of the State of
Delaware without regard to the application of the principles of conflicts or choice of laws.

               (b) Each of the parties hereto hereby submit to the exclusive jurisdiction of the federal or
state courts of the State of Delaware with respect to any action or legal proceeding commenced by
either of them with respect to this Agreement. Each of them irrevocably waives any objection they
now have or hereafter may have respecting the venue of any such action or proceeding brought in
such a court or respecting the fact that such court is an inconvenient forum and consents to the
service of process in any such action or proceeding by means of registered or certified mail,
return receipt requested, in care of the address set forth herein or at such other address as
either of them shall furnish in writing to the other.

               (c) THE PARTIES HERETO EACH HEREBY WAIVE TRIAL BY JURY IN ANY ACTION OR PROCEEDING INVOLVING
ANY MATTER (WHETHER SOUNDING IN

-23-

 

TORT, CONTRACT, FRAUD OR OTHERWISE) IN ANY WAY ARISING OUT OF OR RELATING TO THIS AGREEMENT.

          Section 3.5 Severability. Whenever possible, each provision or portion of any provision of this Agreement will be
interpreted in such manner as to be effective and valid under applicable law but if any provision
or portion of any provision of this Agreement is held to be invalid, illegal or unenforceable in
any respect under any applicable law in any jurisdiction, such invalidity, illegality or
unenforceability will not affect any other provision or portion of any provision in such
jurisdiction, and this agreement will be reformed, construed and enforced in such jurisdiction as
if such invalid, illegal or unenforceable provision or portion of any provision had never been
contained therein.

          Section 3.6 Amendment; Waiver.

               (a) This Agreement may not be amended or modified and waivers and consents to departures from
the provisions hereof (each, an “Amendment”) may not be given, except by an instrument or
instruments in writing making specific reference to this Agreement and signed by the Company and
the Holders of Registrable Securities representing at least a majority of the aggregate Registrable
Securities held by the Holders; provided, however, that any Amendment that treats any Holder in a
series or class of stock (the “Adversely Affected Holder”) in a manner which is
disproportionate and adverse relative to its treatment of the other Holders in such series or class
of stock shall require the consent of the Adversely Affected Holder. For purposes of the foregoing
sentence, the A Holders shall be considered a “group of Holders” and the B Holders shall be
considered a “group of Holders.” Each Holder of any Registrable Securities at the time or
thereafter outstanding shall be bound by any Amendment authorized by this Section 3.6(a). For
purposes of this Section 3.6(a), determinations of whether an Amendment disproportionately effects
any Holder or group of Holders, or whether the Amendment provides a disproportionate benefit to any
Holder or group of Holders, shall be based on such Holder’s (or group’s) contractual rights as of
the time of the Amendment.

               (b) The waiver by any party to this Agreement of a breach of any provision of this Agreement
shall not operate or be construed as a further or continuing waiver of such breach or as a waiver
of any other or subsequent breach. Except as otherwise expressly provided herein, no failure on
the part of any party to exercise, and no delay in exercising, any right, power or remedy
hereunder, or otherwise available in respect hereof at law or in equity, shall operate as a waiver
thereof, nor shall any single or partial exercise of such right, power or remedy by such party
preclude any other or further exercise thereof or the exercise of any other right, power or remedy.

          Section 3.7 Counterparts; Facsimile Signatures. This Agreement may be executed in any number of separate counterparts and by the parties to
this Agreement in separate counterparts each of which when so executed, including by facsimile
signature, shall be deemed to be an original and all of which together shall constitute one and the
same agreement.

          Section 3.8 Entire Agreement. This Agreement constitutes the entire agreement and understanding between the parties hereto
and supersedes any and all prior agreements and understandings, written or oral, relating to the
subject matter of this Agreement.

[Signature Page Follows]

-24-

 

     IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed as of the date
first written above.

	 	 	 	 	 	 	 	 	 	 	 
	 	 	LULULEMON CORP.
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	By:	 	/s/ Robert Meers
	 	 	Name:	 	Robert Meers
	 	 	Title:	 	Chief Executive Officer
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	A HOLDERS:
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	ADVENT INTERNATIONAL GPE V LIMITED PARTNERSHIP
	 	 	ADVENT INTERNATIONAL GPE V-A LIMITED PARTNERSHIP
	 	 	ADVENT INTERNATIONAL GPE V-B LIMITED PARTNERSHIP
	 	 	ADVENT INTERNATIONAL GPE V-G LIMITED PARTNERSHIP
	 	 	ADVENT INTERNATIONAL GPE V-I LIMITED PARTNERSHIP
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	By:	 	GPE V GP Limited Partnership, General Partner
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	 	 	By:	 	Advent International LLC, General Partner
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	By:	 	Advent International Corporation, Manager
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	 

	 	 	 	 	 	By:
	 	/s/ Steven J. Collins
	 	 	 

	 	 	 	 	 	 	 	Name: Steven J. Collins
	 	 	 

	 	 	 	 	 	 	 	Title: Vice President
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	ADVENT PARTNERS III LIMITED PARTNERSHIP
	 	 	ADVENT PARTNERS GPE V LIMITED PARTNERSHIP
	 	 	ADVENT PARTNERS GPE V-A LIMITED PARTNERSHIP
	 	 	ADVENT PARTNERS GPE V-B LIMITED PARTNERSHIP
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	By:	 	Advent International LLC, General Partner
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	 	 	By:	 	Advent International Corporation, Manager
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	By:	 	/s/ Steven J. Collins
	 	 	 	 	 	 	 	 	Name: Steven J. Collins
	 	 	 	 	 	 	 	 	Title: Vice President

 

 

	 	 	 	 	 	 	 	 	 	 	 
	 	 	BROOKE PRIVATE EQUITY ADVISORS FUND I-A, L.P.
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	By:	 	Brooke Private Equity Advisors, L.P., its General Partner
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	 	 	By:	 	Brooke Private Equity Management LLC, its General Partner
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	By:	 	/s/ John Brooke
	 	 	 	 	 	 	Name: John Brooke
	 	 	 	 	 	 	Title: Manager
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	BROOKE PRIVATE EQUITY ADVISORS FUND I (D), L.P.
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	By:	 	Brooke Private Equity Advisors, L.P., its General Partner
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	 	 	By:	 	Brooke Private Equity Management LLC, its General Partner
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	By:	 	/s/ John Brooke
	 	 	 	 	 	 	Name: John Brooke
	 	 	 	 	 	 	Title: Manager

 

 

	 	 	 	 	 	 	 	 	 	 	 
	 	 	HIGHLAND CAPITAL PARTNERS VI LIMITED PARTNERSHIP
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	By:	 	Highland Management Partners VI Limited Partnership, its General Partner
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	 	 	By:	 	Highland Management Partners VI, Inc., its General Partner
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	By:	 	/s/ Paul E. Maeder
	 	 	 

	 	 	 	 	 	Authorized Officer
	 	 	 
	 	 	 	 	 	 	 	 
	 	 	HIGHLAND CAPITAL PARTNERS VI-B LIMITED PARTNERSHIP
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	By:	 	Highland Management Partners VI Limited Partnership, its General Partner
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	 	 	By:	 	Highland Management Partners VI, Inc., its General Partner
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	By:	 	/s/ Paul E. Maeder
	 	 	 	 	 	 	 	 	Authorized Officer
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	HIGHLAND ENTREPRENEURS’ FUND VI LIMITED PARTNERSHIP
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	By:	 	HEF VI Limited Partnership, its General Partner
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	 	 	By:	 	Highland Management Partners VI, Inc., its General Partner
	 
	 	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	By:	 	/s/ Paul E.
Maeder
	 	 	 	 	 	 	 	 	Authorized Officer

 

 

/s/ Susanne Conrad

Susanne Conrad

/s/ R. Brad Martin

R. Brad Martin

/s/ Rhoda Pitcher

Rhoda Pitcher

 

 

B HOLDERS:

DENNIS WILSON

By: /s/ Dennis Wilson

Name: Dennis Wilson

Title: Authorized Signatory

FIVE BOYS INVESTMENT, ULC

By: /s/ Dennis Wilson

Name:

Title: Authorized Signatory

OYOYO HOLDINGS, INC.

By: /s/ Dennis Wilson

Name:

Title: Authorized Signatory

LIPO INVESTMENTS (USA) INC.

By: /s/ Dennis Wilson

Name: Dennis Wilson

Title: Authorized Signatory

SLINKY FINANCIAL ULC

By: /s/ Dennis Wilson

Name: Dennis Wilson

Title: Authorized Signatory

 

 

SCHEDULE A

A Holders

	 	 	 
	Name of Stockholder	 	Address for Notice
	Advent International GPE V Limited Partnership 

Advent International GPE V-A Limited Partnership 

Advent International GPE V-B Limited Partnership 

Advent International GPE V-G Limited Partnership 

Advent International GPE V-I Limited Partnership 

Advent Partners III Limited Partnership 

Advent Partners GPE V Limited Partnership 

Advent Partners GPE V-A Limited Partnership 

Advent Partners GPE V-B Limited Partnership

	 	c/o Advent International Corporation

75 State Street

Boston, MA 02109

Facsimile: (617) 951-0568

Attention: Steven J. Collins

with a copy to:

Pepper Hamilton LLP

3000 Two Logan Square

Eighteenth & Arch Streets

Philadelphia, PA 19103

Facsimile: (215) 981-4750

Attention: Robert A. Friedel
	 
	 	 
	Brooke Private Equity Advisors Fund I-A, L.P.

Brooke Private Equity Advisors Fund I (D), L.P.

	 	c/o Brooke Private Equity Advisors

84 State Street, Suite 320

Boston, MA 02109

Attention: Charlie Bridge

Facsimile Number: (617) 227-4128

with a copy to:

c/o Brooke Private Equity Advisors

84 State Street, Suite 320

Boston, MA 02109

Attention: John Brooke

Facsimile Number: (617) 227-4128
	 
	 	 
	Highland Capital Partners VI Limited Partnership 

Highland Capital Partners VI-B Limited Partnership 

Highland Entrepreneurs’ Fund VI Limited Partnership

	 	c/o Highland Capital Partners, Inc.

92 Hayden Avenue

Lexington, Massachusetts 02421

Facsimile: (781) 861-5499

Attention: Kathleen A. Barry, 

                 Chief Financial Officer

with a copy to:

Goodwin Procter LLP

53 State Street

Boston MA 02109

Facsimile Number: (617) 523-1231 

Attention: William J. Schnoor, Jr.

	Susanne Conrad

	 	1312 Cedar St

Santa Monica, CA 90405

Facsimile Number:___

A-1

 

	 	 	 
	Name of Stockholder	 	Address for Notice
	R. Brad Martin

	 	c/o RBM Venture Co.

1025 Cherry Rd.

Memphis, TN 38117

Facsimile Number:___
	 
	 	 
	Rhoda Pitcher

	 	8610 NE 23rd PL

Clyde Hill WA 98004

Facsimile Number: ___

A-2 

 

SCHEDULE B

B Holders

	 	 	 
	Name of Stockholder	 	Address for Notice
	Dennis Wilson

	 	#2 — 2108 West 4th Avenue

Vancouver, BC, V6K 1N6

Attention: Dennis Wilson

Facsimile Number: (604) 737-7267

with a copy to:

McCullough O’Connor Irwin LLP

#1100 888 Dunsmuir St.

Vancouver, BC V6C 3K4

Facsimile: (604) 687-7099

Attention: Jonathan McCullough
	 
	 	 
	Five Boys Investment ULC

	 	#2 — 2108 West 4th Avenue

Vancouver, BC, V6K 1N6

Attention: Dennis Wilson

Facsimile Number: (604) 737-7267

with a copy to:

McCullough O’Connor Irwin LLP

#1100 888 Dunsmuir St.

Vancouver, BC V6C 3K4

Facsimile: (604) 687-7099

Attention: Jonathan McCullough
	 
	 	 
	Oyoyo Holdings, Inc.

	 	#2 — 2108 West 4th Avenue

Vancouver, BC, V6K 1N6

Attention: Dennis Wilson

Facsimile Number: (604) 737-7267

with a copy to:

McCullough O’Connor Irwin LLP

#1100 888 Dunsmuir St.

Vancouver, BC V6C 3K4

Facsimile: (604) 687-7099

Attention: Jonathan McCullough

B-1 

 

	 	 	 
	Name of Stockholder	 	Address for Notice
	LIPO Investments (USA) Inc.

	 	#2 — 2108 West 4th Avenue

Vancouver, BC, V6K 1N6

Attention: Dennis Wilson

Facsimile Number: (604) 737-7267

with a copy to:

McCullough O’Connor Irwin LLP

#1100 888 Dunsmuir St.

Vancouver, BC V6C 3K4

Facsimile: (604) 687-7099

Attention: Jonathan McCullough
	 
	 	 
	Slinky Financial ULC

	 	#2 — 2108 West 4th Avenue

Vancouver, BC, V6K 1N6

Attention: Dennis Wilson

Facsimile Number: (604) 737-7267

with a copy to:

McCullough O’Connor Irwin LLP

#1100 888 Dunsmuir St.

Vancouver, BC V6C 3K4

Facsimile: (604) 687-7099

Attention: Jonathan McCullough

B-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}]]